A	O
cell	B-DNA
type-specific	I-DNA
enhancer	I-DNA
in	O
the	O
human	B-DNA
B7.1	I-DNA
gene	I-DNA
regulated	O
by	O
NF-kappaB	B-protein
.	O

The	O
costimulatory	B-protein
molecule	I-protein
B7.1	I-protein
provides	O
a	O
second	O
signal	O
critical	O
for	O
T	O
cell	O
activation	O
.	O

The	O
distribution	O
of	O
this	O
integral	B-protein
membrane	I-protein
protein	I-protein
is	O
restricted	O
to	O
certain	O
tissues	O
where	O
its	O
level	O
of	O
expression	O
is	O
modulated	O
by	O
multiple	O
exogenous	O
stimuli	O
.	O

To	O
identify	O
the	O
molecular	O
basis	O
for	O
specificity	O
and	O
inducibility	O
,	O
the	O
chromatin	B-DNA
configuration	O
of	O
the	O
human	B-DNA
B7.1	I-DNA
gene	I-DNA
was	O
examined	O
in	O
intact	O
nuclei	O
from	O
various	O
cell	O
types	O
.	O

The	O
identification	O
of	O
a	O
tissue-specific	O
deoxyribonuclease	B-DNA
I	I-DNA
hypersensitive	I-DNA
site	I-DNA
approximately	O
3kb	B-DNA
upstream	I-DNA
of	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
led	O
to	O
the	O
characterization	O
of	O
a	O
cell	B-DNA
type-specific	I-DNA
enhancer	I-DNA
region	I-DNA
.	O

This	O
183-bp	B-DNA
region	I-DNA
was	O
both	O
cell	O
type	O
specific	O
and	O
responsive	O
to	O
two	O
distinct	O
stimuli	O
,	O
lipopolysaccharide	O
and	O
dibutyryl	O
cAMP	O
,	O
known	O
to	O
regulate	O
B7.1	B-protein
expression	O
.	O

Deletional	O
and	O
site-directed	O
mutagenesis	O
revealed	O
the	O
presence	O
of	O
multiple	O
functionally	O
critical	O
cis	B-DNA
elements	I-DNA
within	O
this	O
region	O
,	O
one	O
of	O
which	O
was	O
a	O
nuclear	B-DNA
factor	I-DNA
(	I-DNA
NF	I-DNA
)	I-DNA
-kappaB	I-DNA
consensus	I-DNA
sequence	I-DNA
.	O

In	O
B7.1-positive	B-cell_type
B	I-cell_type
cells	I-cell_type
,	O
this	O
element	O
bound	O
several	O
members	O
of	O
the	O
NF-kappaB	B-protein
family	I-protein
,	O
transcription	B-protein
factors	I-protein
already	O
implicated	O
in	O
signal	O
transduction	O
pathways	O
relevant	O
to	O
B7.1	B-protein
expression	O
.	O

This	O
is	O
the	O
first	O
description	O
,	O
to	O
our	O
knowledge	O
,	O
of	O
regulatory	B-DNA
elements	I-DNA
that	O
control	O
expression	O
of	O
a	O
gene	O
encoding	O
a	O
B7	B-protein
costimulatory	I-protein
molecule	I-protein
.	O

A	NULL
Cell	NULL
Type-specific	NULL
Enhancer	NULL
in	NULL
the	NULL
Human	NULL
B7.1	NULL
Gene	NULL
Regulated	NULL
by	NULL
NF-KB	NULL
By	NULL
Ji-liang	NULL
Zhao	NULL
,	NULL
*	NULL
Gordon	NULL
J.	NULL
Freeman	NULL
,	NULL
$	NULL
Gary	NULL
S.	NULL
Gray	NULL
,	NULL
!	NULL

Lee	NULL
M.	NULL
Nadler	NULL
,	NULL
$	NULL
and	NULL
Laurie	NULL
H.	NULL
Glimcher*	NULL
From	NULL
the	NULL
*Department	NULL
of	NULL
Cancer	NULL
Biology	NULL
,	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
the	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
the	NULL
Division	NULL
of	NULL
Hematologic	NULL
Malignancies	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Therapeutics	NULL
Research	NULL
,	NULL
Repligen	NULL
Corporation	NULL
,	NULL
Cambridge	NULL
,	NULL
Massachusetts	NULL
02139	NULL
Summary	NULL
The	NULL
costimulatory	NULL
molecule	NULL
B7.1	NULL
provides	NULL
a	NULL
second	NULL
signal	NULL
critical	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
this	NULL
integral	NULL
membrane	NULL
protein	NULL
is	NULL
restricted	NULL
to	NULL
certain	NULL
tissues	NULL
where	NULL
its	NULL
level	NULL
of	NULL
expression	NULL
is	NULL
modulated	NULL
by	NULL
multiple	NULL
exogenous	NULL
stimuli	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
specificity	NULL
and	NULL
inducibility	NULL
,	NULL
the	NULL
chromatin	NULL
configuration	NULL
of	NULL
the	NULL
human	NULL
B7.1	NULL
gene	NULL
was	NULL
examined	NULL
in	NULL
intact	NULL
nuclei	NULL
from	NULL
various	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
a	NULL
tissue-specific	NULL
deoxyribo-nuclease	NULL
I	NULL
hypersensitive	NULL
site	NULL
~3kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
led	NULL
to	NULL
the	NULL
characterization	NULL
of	NULL
a	NULL
cell	NULL
type-specific	NULL
enhancer	NULL
region	NULL
.	NULL

This	NULL
183-bp	NULL
region	NULL
was	NULL
both	NULL
cell	NULL
type	NULL
specific	NULL
and	NULL
responsive	NULL
to	NULL
two	NULL
distinct	NULL
stimuli	NULL
,	NULL
lipopolysaccharide	NULL
and	NULL
dibutyryl	NULL
cAMP	NULL
,	NULL
known	NULL
to	NULL
regulate	NULL
B7.1	NULL
expression	NULL
.	NULL

Deletional	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
functionally	NULL
critical	NULL
cis	NULL
elements	NULL
within	NULL
this	NULL
region	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-kB	NULL
consensus	NULL
sequence	NULL
.	NULL

In	NULL
B7.1-positive	NULL
B	NULL
cells	NULL
,	NULL
this	NULL
element	NULL
bound	NULL
several	NULL
members	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
,	NULL
transcription	NULL
factors	NULL
already	NULL
implicated	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
relevant	NULL
to	NULL
B7.1	NULL
expression	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
description	NULL
,	NULL
to	NULL
our	NULL
knowledge	NULL
,	NULL
of	NULL
regulatory	NULL
elements	NULL
that	NULL
control	NULL
expression	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
B7	NULL
costimulatory	NULL
molecule	NULL
.	NULL

ffective	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
requires	NULL
two	NULL
sig-	NULL
nals	NULL
from	NULL
APCs	NULL
(	NULL
for	NULL
a	NULL
review	NULL
see	NULL
reference	NULL
1	NULL
)	NULL
.	NULL

The	NULL
first	NULL
signal	NULL
is	NULL
delivered	NULL
upon	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
clonally	NULL
distributed	NULL
TCR	NULL
to	NULL
MHC-foreign	NULL
antigen	NULL
complexes	NULL
on	NULL
APCs	NULL
.	NULL

This	NULL
interaction	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
cellular	NULL
tyrosine	NULL
kinases	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

The	NULL
second	NULL
signal	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
costimulatory	NULL
molecules	NULL
on	NULL
T	NULL
cells	NULL
with	NULL
their	NULL
ligands	NULL
on	NULL
APCs	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
delivery	NULL
of	NULL
signal	NULL
one	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
signal	NULL
two	NULL
can	NULL
lead	NULL
to	NULL
T	NULL
cell	NULL
paralysis	NULL
or	NULL
anergy	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
known	NULL
costimulatory	NULL
molecules	NULL
,	NULL
the	NULL
B7	NULL
family	NULL
of	NULL
proteins	NULL
is	NULL
arguably	NULL
the	NULL
most	NULL
potent	NULL
.	NULL

This	NULL
family	NULL
consists	NULL
of	NULL
at	NULL
least	NULL
two	NULL
members	NULL
,	NULL
B7.1	NULL
(	NULL
CD80	NULL
)	NULL
(	NULL
8	NULL
)	NULL
and	NULL
B7.2	NULL
(	NULL
CD86	NULL
)	NULL
(	NULL
9-11	NULL
)	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
similar	NULL
affinity	NULL
with	NULL
their	NULL
coun-terreceptors	NULL
,	NULL
CD28	NULL
and	NULL
CTLA4	NULL
,	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
their	NULL
affinity	NULL
for	NULL
CTLA4	NULL
is	NULL
substantially	NULL
greater	NULL
than	NULL
for	NULL
CD28	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Blocking	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
B7	NULL
molecules	NULL
by	NULL
excess	NULL
soluble	NULL
CTLA4	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
leads	NULL
to	NULL
hyporesponsiveness	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
B7.1-deficient	NULL
mice	NULL
have	NULL
substantially	NULL
reduced	NULL
immune	NULL
responses	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Blockade	NULL
of	NULL
B7.1	NULL
by	NULL
mAb	NULL
injection	NULL
leads	NULL
to	NULL
amelioration	NULL
of	NULL
autoimmune	NULL
experimental	NULL
allergic	NULL
encephalitis	NULL
,	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
multiple	NULL
sclerosis	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
prevents	NULL
xenograft	NULL
rejection	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
B7.1	NULL
and	NULL
B7.2	NULL
molecules	NULL
have	NULL
similar	NULL
but	NULL
not	NULL
iden-	NULL
tical	NULL
tissue	NULL
distribution	NULL
patterns	NULL
.	NULL

Both	NULL
proteins	NULL
are	NULL
expressed	NULL
on	NULL
dendritic	NULL
cells	NULL
,	NULL
and	NULL
B7.1	NULL
is	NULL
expressed	NULL
on	NULL
activated	NULL
but	NULL
not	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Resting	NULL
B	NULL
cells	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
B7.2	NULL
but	NULL
not	NULL
B7.1	NULL
whereas	NULL
upon	NULL
activation	NULL
,	NULL
B	NULL
cells	NULL
express	NULL
substantial	NULL
levels	NULL
of	NULL
both	NULL
proteins	NULL
(	NULL
10	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
macrophages	NULL
constitutively	NULL
express	NULL
B7.2	NULL
and	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
express	NULL
higher	NULL
levels	NULL
of	NULL
B7	NULL
proteins	NULL
upon	NULL
IFN-y	NULL
treatment	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
in	NULL
mice	NULL
,	NULL
cell	NULL
surface	NULL
B7.2	NULL
levels	NULL
are	NULL
higher	NULL
than	NULL
B7.1	NULL
levels	NULL
,	NULL
and	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
B7.2	NULL
are	NULL
faster	NULL
than	NULL
those	NULL
of	NULL
B7.1	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

A	NULL
large	NULL
number	NULL
of	NULL
stimuli	NULL
can	NULL
induce	NULL
B7.1	NULL
expression	NULL
on	NULL
resting	NULL
,	NULL
surface-negative	NULL
B	NULL
cells	NULL
,	NULL
These	NULL
include	NULL
the	NULL
cytokine	NULL
IL-4	NULL
(	NULL
24	NULL
)	NULL
,	NULL
Abs	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
Ig	NULL
receptor	NULL
(	NULL
23	NULL
)	NULL
,	NULL
ligation	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
activation	NULL
molecule	NULL
CD40	NULL
(	NULL
25	NULL
)	NULL
,	NULL
the	NULL
mitogens	NULL
LPS	NULL
and	NULL
dextran	NULL
sulfate	NULL
(	NULL
23	NULL
)	NULL
,	NULL
transformation	NULL
by	NULL
EBV	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
agents	NULL
that	NULL
activate	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
such	NULL
as	NULL
dibutyryl	NULL
cyclic	NULL
AMP	NULL
(	NULL
db-cAMP	NULL
)	NULL
!	NULL

(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Since	NULL
resting	NULL
B	NULL
cells	NULL
do	NULL
not	NULL
contain	NULL
detectable	NULL
transcripts	NULL
for	NULL
B7.1	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
such	NULL
induction	NULL
occurs	NULL
primarily	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

Similarly	NULL
,	NULL
B7.1-negative	NULL
monocytes	NULL
become	NULL
B7.1	NULL
positive	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
db-cAMP	NULL
,	NULL
dibutyl	NULL
cyclic	NULL
AMP	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
HTLV-1	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type-1	NULL
;	NULL
NF-KB	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
;	NULL
NIB	NULL
,	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
;	NULL
tk	NULL
,	NULL
thymidine	NULL
kinase	NULL
.	NULL

777	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/96/03/777/13	NULL
$	NULL
2.00	NULL
Volume	NULL
183	NULL
March	NULL
1996	NULL
777-789	NULL
after	NULL
treatment	NULL
with	NULL
IFN-y	NULL
(	NULL
29	NULL
)	NULL
,	NULL
as	NULL
do	NULL
resting	NULL
T	NULL
cells	NULL
upon	NULL
activation	NULL
by	NULL
antigen	NULL
or	NULL
transformation	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type-1	NULL
(	NULL
HTLV-1	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
stimuli	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
the	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
B	NULL
transcription	NULL
factor	NULL
in	NULL
other	NULL
systems	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
B7.1	NULL
genes	NULL
have	NULL
been	NULL
isolated	NULL
(	NULL
8	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
human	NULL
cDNA	NULL
as	NULL
probe	NULL
,	NULL
four	NULL
transcripts	NULL
sized	NULL
1.7	NULL
,	NULL
2.9	NULL
,	NULL
4.2	NULL
,	NULL
and	NULL
10	NULL
kb	NULL
were	NULL
detected	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
2.9	NULL
kb	NULL
transcript	NULL
was	NULL
the	NULL
major	NULL
species	NULL
in	NULL
anti-Ig-activated	NULL
B	NULL
cells	NULL
whereas	NULL
the	NULL
1.7-kb	NULL
transcript	NULL
predominated	NULL
in	NULL
B	NULL
tumor	NULL
cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
three	NULL
transcripts	NULL
,	NULL
2.2	NULL
,	NULL
3.9	NULL
,	NULL
and	NULL
10	NULL
kb	NULL
were	NULL
detected	NULL
in	NULL
spleen	NULL
and	NULL
transformed	NULL
B	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
variation	NULL
in	NULL
transcript	NULL
lengths	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

The	NULL
genomic	NULL
organization	NULL
of	NULL
both	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
genes	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
the	NULL
B7.1	NULL
locus	NULL
spans	NULL
~32	NULL
kb	NULL
.	NULL

A	NULL
primer	NULL
extension	NULL
analysis	NULL
of	NULL
mRNAs	NULL
from	NULL
Raji	NULL
and	NULL
CH1	NULL
B	NULL
cells	NULL
has	NULL
shown	NULL
that	NULL
transcription	NULL
of	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
B7.1	NULL
initiates	NULL
within	NULL
about	NULL
60	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
5	NULL
``	NULL
end	NULL
of	NULL
the	NULL
existing	NULL
cDNA	NULL
clones	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
obvious	NULL
promoter	NULL
elements	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
abutting	NULL
the	NULL
putative	NULL
transcription	NULL
start	NULL
sites	NULL
.	NULL

Recently	NULL
,	NULL
Bortielio	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
used	NULL
RACE	NULL
(	NULL
5	NULL
reverse	NULL
amplification	NULL
cDNA	NULL
ends	NULL
)	NULL
on	NULL
RNA	NULL
isolated	NULL
from	NULL
CH1	NULL
B	NULL
cells	NULL
to	NULL
extend	NULL
the	NULL
5	NULL
``	NULL
end	NULL
of	NULL
the	NULL
previously	NULL
published	NULL
mB7.1	NULL
cDNA	NULL
by	NULL
1.5	NULL
kb	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
additional	NULL
5	NULL
'	NULL
untranslated	NULL
sequence	NULL
may	NULL
account	NULL
for	NULL
the	NULL
variation	NULL
in	NULL
transcript	NULL
length	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
B7.1	NULL
promoter	NULL
.	NULL

We	NULL
provide	NULL
evidence	NULL
for	NULL
an	NULL
enhancer	NULL
region	NULL
located	NULL
~3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
which	NULL
determines	NULL
both	NULL
cell	NULL
type	NULL
specificity	NULL
and	NULL
inducibility	NULL
by	NULL
certain	NULL
stimuli	NULL
.	NULL

Linker-scanning	NULL
mutagenesis	NULL
of	NULL
this	NULL
region	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
NF-KB	NULL
consensus	NULL
binding	NULL
site	NULL
and	NULL
several	NULL
additional	NULL
sites	NULL
whose	NULL
integrity	NULL
was	NULL
critical	NULL
for	NULL
enhancer	NULL
function	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Isolation	NULL
,	NULL
Cloning	NULL
,	NULL
and	NULL
Sequencing	NULL
of	NULL
the	NULL
5°	NULL
Flanking	NULL
Region	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
.	NULL

A	NULL
full-length	NULL
human	NULL
B7.1	NULL
cDNA	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
leukocyte	NULL
genomic	NULL
DNA	NULL
library	NULL
in	NULL
A	NULL
EMBL-3	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
S.	NULL
Orkin	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
screening	NULL
procedure	NULL
was	NULL
as	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
from	NULL
10	NULL
positive	NULL
clones	NULL
was	NULL
prepared	NULL
,	NULL
digested	NULL
with	NULL
restriction	NULL
endonucleases	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
separated	NULL
DNA	NULL
fragments	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
and	NULL
probed	NULL
with	NULL
P-labeled	NULL
oligonucleotides	NULL
representing	NULL
sequences	NULL
derived	NULL
from	NULL
different	NULL
domains	NULL
of	NULL
the	NULL
B7.1	NULL
gene	NULL
.	NULL

The	NULL
procedures	NULL
of	NULL
prehybrid-ization	NULL
,	NULL
hybridization	NULL
,	NULL
and	NULL
washing	NULL
of	NULL
filters	NULL
were	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

One	NULL
clone	NULL
,	NULL
AUT-1	NULL
,	NULL
hybridized	NULL
to	NULL
probes	NULL
from	NULL
the	NULL
first	NULL
and	NULL
second	NULL
exons	NULL
of	NULL
the	NULL
B7.1	NULL
gene	NULL
.	NULL

The	NULL
DNA	NULL
of	NULL
this	NULL
clone	NULL
was	NULL
further	NULL
mapped	NULL
by	NULL
digestion	NULL
with	NULL
restriction	NULL
endonucleases	NULL
,	NULL
and	NULL
various	NULL
subfragments	NULL
recovered	NULL
from	NULL
agarose	NULL
gels	NULL
were	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
KS	NULL
(	NULL
Stratagene	NULL
Inc.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
3.3-kb	NULL
Sacl	NULL
subclone	NULL
containing	NULL
the	NULL
first	NULL
exon	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
a	NULL
series	NULL
of	NULL
nested	NULL
deletions	NULL
using	NULL
the	NULL
Erase-a-Base	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

The	NULL
overlapping	NULL
deletion	NULL
clones	NULL
were	NULL
sequenced	NULL
on	NULL
both	NULL
778	NULL
Regulation	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
strands	NULL
using	NULL
dye-labeled	NULL
terminator/Taq	NULL
polymerase	NULL
chemistry	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
automated	NULL
fluorescence	NULL
DNA	NULL
sequencer	NULL
(	NULL
Ap-plied	NULL
Biosystems	NULL
,	NULL
Inc.	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
2.4-kb	NULL
BamHI-Sacl	NULL
fragment	NULL
was	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxynucleotide	NULL
chain-termination/extension	NULL
method	NULL
(	NULL
36	NULL
)	NULL
and	NULL
Sequenase	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
Corp.	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
using	NULL
B7.1-specific	NULL
oligonucleotide	NULL
primers	NULL
.	NULL

The	NULL
sequence	NULL
was	NULL
analyzed	NULL
with	NULL
the	NULL
Genetic	NULL
Computer	NULL
Group	NULL
(	NULL
GCG	NULL
)	NULL
package	NULL
(	NULL
37	NULL
)	NULL
and	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
.	NULL

Cell	NULL
Lines	NULL
.	NULL

-	NULL
Human	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
lines	NULL
BL30	NULL
,	NULL
EBV5	NULL
,	NULL
and	NULL
SKW	NULL
were	NULL
obtained	NULL
from	NULL
Dr.	NULL
J.	NULL
Fingeroth	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
,	NULL
the	NULL
Nalm6-transformed	NULL
pre-B	NULL
cell	NULL
line	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Ritz	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
,	NULL
and	NULL
the	NULL
BA	NULL
cell	NULL
line	NULL
came	NULL
from	NULL
Dr.	NULL
S.	NULL
Lederman	NULL
(	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
)	NULL
.	NULL

Other	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
the	NULL
epitheloid	NULL
carcinoma	NULL
HeLa	NULL
,	NULL
the	NULL
hepatocellular	NULL
carcinoma	NULL
HepG2	NULL
,	NULL
the	NULL
leukemic	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
,	NULL
the	NULL
small	NULL
cell	NULL
lung	NULL
carcinoma	NULL
NCI-H146	NULL
,	NULL
the	NULL
Burkitt	NULL
lymphoma	NULL
Raji	NULL
and	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
Ramos	NULL
,	NULL
and	NULL
the	NULL
mouse	NULL
myeloid	NULL
cell	NULL
line	NULL
M1	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
human	NULL
fibroblast	NULL
GMO00637	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
Coriell	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
(	NULL
Camden	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

M12.4.1	NULL
is	NULL
a	NULL
BALB/c	NULL
B	NULL
lymphoma	NULL
cell	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Hela	NULL
,	NULL
HepG2	NULL
,	NULL
and	NULL
GMO00637	NULL
were	NULL
grown	NULL
in	NULL
DME	NULL
,	NULL
and	NULL
all	NULL
other	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.3	NULL
.	NULL

All	NULL
culture	NULL
media	NULL
were	NULL
supplemented	NULL
with	NULL
8	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
HyClone	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
50	NULL
wM	NULL
2-ME	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
for	NULL
M1	NULL
also	NULL
contained	NULL
100	NULL
pM	NULL
nonessential	NULL
amino	NULL
acids	NULL
.	NULL

Abs	NULL
and	NULL
Flow	NULL
Cytometry	NULL
.	NULL

-	NULL
Anti-hB7.1	NULL
mAb	NULL
133	NULL
(	NULL
mouse	NULL
IgM	NULL
)	NULL
(	NULL
39	NULL
)	NULL
and	NULL
anti-mB7.1	NULL
mAb	NULL
1G10	NULL
(	NULL
rat	NULL
IgG2a	NULL
)	NULL
(	NULL
27	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
mAbs	NULL
MIgM	NULL
,	NULL
«	NULL
and	NULL
RigG2a	NULL
,	NULL
«	NULL
were	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
used	NULL
as	NULL
isotype-matched	NULL
control	NULL
Abs	NULL
for	NULL
human	NULL
or	NULL
mouse	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
control	NULL
Ab	NULL
or	NULL
anti-B7.1	NULL
mAb	NULL
at	NULL
4°C	NULL
in	NULL
HBSS	NULL
containing	NULL
3	NULL
%	NULL
BSA	NULL
and	NULL
0.1	NULL
%	NULL
NaN	NULL
,	NULL
.	NULL

After	NULL
wash-ing	NULL
,	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
FITC-conju-gated	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
(	NULL
Tago	NULL
,	NULL
Inc.	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
FITC	NULL
goat	NULL
anti-rat	NULL
IgG	NULL
(	NULL
Kirkegaard	NULL
&	NULL
Perry	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
FACS®	NULL
analyzer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Hypersensitive	NULL
Site	NULL
Mapping	NULL
.	NULL

-	NULL
Isolation	NULL
and	NULL
DNase	NULL
I	NULL
digestion	NULL
of	NULL
nuclei	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10°	NULL
cells	NULL
in	NULL
log	NULL
phase	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
ml	NULL
of	NULL
ice-cold	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
(	NULL
NIB	NULL
)	NULL
(	NULL
15	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
15	NULL
mM	NULL
NaCl	NULL
,	NULL
300	NULL
mM	NULL
sucrose	NULL
,	NULL
5	NULL
mM	NULL
MgC	NULL
)	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
}	NULL
)	NULL
containing	NULL
0.4	NULL
%	NULL
NP-40	NULL
.	NULL

Cells	NULL
were	NULL
permeablized	NULL
for	NULL
5	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
centrifuged	NULL
at	NULL
3,000	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Nuclei	NULL
collected	NULL
were	NULL
resuspended	NULL
in	NULL
0.5	NULL
tl	NULL
of	NULL
NIB	NULL
and	NULL
aliquoted	NULL
into	NULL
five	NULL
tubes	NULL
containing	NULL
100	NULL
pl	NULL
of	NULL
NIB	NULL
plus	NULL
0-5	NULL
pug	NULL
of	NULL
DNase	NULL
I	NULL
.	NULL

After	NULL
4	NULL
min	NULL
at	NULL
room	NULL
tempera-ture	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
250	NULL
pl	NULL
of	NULL
stop	NULL
solution	NULL
(	NULL
63	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
2.5	NULL
mM	NULL
EDTA	NULL
and	NULL
1.25	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
50	NULL
pul	NULL
of	NULL
proteinase	NULL
K	NULL
(	NULL
5	NULL
mg/ml	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
incubated	NULL
overnight	NULL
at	NULL
37°C	NULL
and	NULL
proteins	NULL
were	NULL
removed	NULL
by	NULL
phenol/chloro-form	NULL
extraction	NULL
.	NULL

The	NULL
genomic	NULL
DNAs	NULL
isolated	NULL
were	NULL
digested	NULL
by	NULL
BamHI	NULL
,	NULL
Sacl	NULL
,	NULL
or	NULL
Xhol	NULL
and	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
agarose	NULL
gels	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
blotted	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
P-labeled	NULL
295-bp	NULL
Scal-BamHI	NULL
probe	NULL
,	NULL
spanning	NULL
exon	NULL
1	NULL
of	NULL
the	NULL
hB7.1	NULL
gene	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Expression	NULL
Plasmid	NULL
Construction	NULL
.	NULL

The	NULL
3.3-kb	NULL
Sacl	NULL
and	NULL
5-kb	NULL
BamHI	NULL
fragments	NULL
containing	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
B7	NULL
.	NULL

1	NULL
gene	NULL
were	NULL
released	NULL
from	NULL
pBluescript	NULL
clones	NULL
and	NULL
purified	NULL
from	NULL
agarose	NULL
gels	NULL
.	NULL

These	NULL
fragments	NULL
were	NULL
inserted	NULL
into	NULL
pSyncatl	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
a	NULL
promoterless	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
SynapSys	NULL
,	NULL
Bur-lington	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
5-kb	NULL
BamHI	NULL
fragment	NULL
and	NULL
a	NULL
2.8-kb	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
DH	NULL
site	NULL
B	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
isolated	NULL
and	NULL
inserted	NULL
into	NULL
pSyncatHII	NULL
,	NULL
a	NULL
vector	NULL
that	NULL
contains	NULL
the	NULL
minimal	NULL
herpes	NULL
virus	NULL
thymidine	NULL
kinase	NULL
(	NULL
tk	NULL
)	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

Subsequently	NULL
,	NULL
these	NULL
clones	NULL
were	NULL
digested	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
restriction	NULL
enzymes	NULL
to	NULL
systematically	NULL
remove	NULL
different	NULL
parts	NULL
of	NULL
the	NULL
larger	NULL
fragments	NULL
.	NULL

Subclones	NULL
of	NULL
the	NULL
shorter	NULL
B7.1	NULL
DNA	NULL
fragments	NULL
were	NULL
regenerated	NULL
by	NULL
ligation	NULL
of	NULL
blunted	NULL
ends	NULL
.	NULL

Transient	NULL
Transfections	NULL
,	NULL
Induction	NULL
,	NULL
and	NULL
CAT	NULL
Assays	NULL
.	NULL

-	NULL
Raji	NULL
B	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
using	NULL
an	NULL
electroporator	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
described	NULL
(	NULL
41	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
standard	NULL
calcium	NULL
phosphate	NULL
technique	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Transfections	NULL
of	NULL
BA	NULL
B	NULL
cells	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
performed	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
STBS	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
MgCl	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
200	NULL
pg/ml	NULL
)	NULL
plus	NULL
6	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
DEAE-dextran/DNA	NULL
mixture	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
complete	NULL
medium	NULL
,	NULL
and	NULL
plated	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

M12.4.1	NULL
(	NULL
abbreviated	NULL
as	NULL
M12	NULL
hereafter	NULL
)	NULL
B	NULL
cells	NULL
and	NULL
M1	NULL
myeloid	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
an	NULL
alternative	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
split	NULL
equally	NULL
into	NULL
two	NULL
sets	NULL
of	NULL
plates	NULL
and	NULL
incubated	NULL
for	NULL
24	NULL
h.	NULL
db-cAMP	NULL
and	NULL
LPS	NULL
(	NULL
both	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
were	NULL
added	NULL
to	NULL
appropriate	NULL
plates	NULL
of	NULL
M12	NULL
cells	NULL
at	NULL
30	NULL
and	NULL
5	NULL
pg/ml	NULL
,	NULL
respectively	NULL
.	NULL

M1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
at	NULL
10	NULL
ng/ml	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
18	NULL
h	NULL
after	NULL
db-cAMP	NULL
treatment	NULL
or	NULL
at	NULL
24	NULL
h	NULL
after	NULL
LPS	NULL
stimulation	NULL
.	NULL

Protein	NULL
concentration	NULL
of	NULL
cell	NULL
extracts	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
protein	NULL
assay	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
used	NULL
in	NULL
CAT	NULL
assays	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

CAT	NULL
activities	NULL
of	NULL
hB7.1	NULL
DNA	NULL
transfections	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
over	NULL
those	NULL
of	NULL
the	NULL
vector	NULL
DNA	NULL
transfections	NULL
,	NULL
which	NULL
were	NULL
arbitrarily	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
repeated	NULL
three	NULL
times	NULL
unless	NULL
otherwise	NULL
specified	NULL
.	NULL

The	NULL
NF-KB	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
constructs	NULL
were	NULL
the	NULL
gift	NULL
of	NULL
Dr.	NULL
R.	NULL
Sen	NULL
(	NULL
Brandeis	NULL
University	NULL
,	NULL
Waltham	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Mutagenesis	NULL
of	NULL
the	NULL
B7.1	NULL
Enhancer	NULL
.	NULL

-	NULL
Deletion	NULL
and	NULL
linker-scanning	NULL
mutants	NULL
of	NULL
the	NULL
183-bp	NULL
B7.1	NULL
enhancer	NULL
were	NULL
made	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
synthesized	NULL
oligonucleotides	NULL
(	NULL
oligos	NULL
)	NULL
.	NULL

A	NULL
665-bp	NULL
Pvull	NULL
fragment	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
183-bp	NULL
Stul-Apal	NULL
enhancer	NULL
pSyncatll	NULL
clone	NULL
and	NULL
used	NULL
as	NULL
the	NULL
PCR	NULL
ternplate	NULL
.	NULL

The	NULL
template	NULL
contained	NULL
pSyncatlII	NULL
sequences	NULL
and	NULL
restrection	NULL
sites	NULL
Sacll	NULL
and	NULL
BamHI	NULL
flanking	NULL
the	NULL
5	NULL
``	NULL
and	NULL
3	NULL
``	NULL
end	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
respectively	NULL
.	NULL

Oligos	NULL
used	NULL
to	NULL
construct	NULL
the	NULL
5	NULL
``	NULL
and	NULL
3	NULL
``	NULL
deletions	NULL
of	NULL
the	NULL
enhancer	NULL
also	NULL
contained	NULL
Sacll	NULL
or	NULL
BamHI	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
3	NULL
'	NULL
portions	NULL
of	NULL
the	NULL
enhancer	NULL
were	NULL
obtained	NULL
by	NULL
PCR	NULL
with	NULL
Sacll-containing	NULL
oligos	NULL
and	NULL
an	NULL
oligo	NULL
downstream	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
whereas	NULL
the	NULL
5	NULL
``	NULL
portions	NULL
were	NULL
obtained	NULL
by	NULL
PCR	NULL
with	NULL
BamHlI-containing	NULL
oligos	NULL
and	NULL
an	NULL
oligo	NULL
upstream	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
central	NULL
portion	NULL
of	NULL
the	NULL
enhancer	NULL
was	NULL
obtained	NULL
by	NULL
PCR	NULL
with	NULL
a	NULL
pair	NULL
of	NULL
the	NULL
B7.1	NULL
oligos	NULL
flanking	NULL
the	NULL
region	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Sacll	NULL
and	NULL
BamHI	NULL
and	NULL
different	NULL
portions	NULL
of	NULL
the	NULL
enhancer	NULL
were	NULL
recovered	NULL
from	NULL
agarose	NULL
gels	NULL
and	NULL
recloned	NULL
into	NULL
pSyncatIl	NULL
.	NULL

Linker-scanning	NULL
mutagenesis	NULL
was	NULL
performed	NULL
by	NULL
a	NULL
modified	NULL
over-lap-extension	NULL
method	NULL
as	NULL
described	NULL
(	NULL
44	NULL
)	NULL
.	NULL

In	NULL
total	NULL
,	NULL
18	NULL
unique	NULL
oligos	NULL
were	NULL
designed	NULL
to	NULL
contain	NULL
a	NULL
10-bp	NULL
mutant	NULL
sequence	NULL
flanked	NULL
by	NULL
779	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

15-bp	NULL
template	NULL
sequences	NULL
on	NULL
either	NULL
side	NULL
.	NULL

Each	NULL
oligo	NULL
was	NULL
used	NULL
in	NULL
PCR	NULL
to	NULL
introduce	NULL
mutations	NULL
into	NULL
a	NULL
specific	NULL
10-bp	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
without	NULL
changing	NULL
the	NULL
enhancer	NULL
length	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
SaclI	NULL
and	NULL
BamHI	NULL
,	NULL
purified	NULL
from	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
cloned	NULL
back	NULL
into	NULL
pSyncatll	NULL
.	NULL

DNA	NULL
sequencing	NULL
was	NULL
used	NULL
to	NULL
verify	NULL
all	NULL
mutant	NULL
and	NULL
flanking	NULL
sequences	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
and	NULL
Ab	NULL
Inhibition	NULL
.	NULL

-	NULL
Small	NULL
scale	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
10	NULL
``	NULL
Raji	NULL
B	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
45	NULL
)	NULL
.	NULL

An	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
46	NULL
)	NULL
in	NULL
a	NULL
10-pil	NULL
final	NULL
volume	NULL
containing	NULL
8	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.3	NULL
mM	NULL
MgCl	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.8	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
9	NULL
%	NULL
glycerol	NULL
.	NULL

Each	NULL
binding	NULL
reaction	NULL
also	NULL
included	NULL
2.5	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
2	NULL
ug	NULL
nuclear	NULL
extract	NULL
,	NULL
and	NULL
~2	NULL
X	NULL
10+	NULL
cpm	NULL
of	NULL
P-labeled	NULL
probe	NULL
.	NULL

For	NULL
Ab	NULL
inhibition	NULL
,	NULL
antisera	NULL
against	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
and	NULL
Rel-B	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
added	NULL
at	NULL
1	NULL
jug	NULL
per	NULL
reaction	NULL
.	NULL

Oligo	NULL
probes	NULL
and	NULL
specific	NULL
or	NULL
nonspecific	NULL
competitors	NULL
used	NULL
in	NULL
EMSA	NULL
included	NULL
-2983	NULL
to	NULL
-2959	NULL
of	NULL
the	NULL
hB7.1	NULL
enhancer	NULL
(	NULL
5'-GGGAAAGGGGTTTTCCCAGCAGTCA-3	NULL
'	NULL
)	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
of	NULL
the	NULL
Igx	NULL
enhancer	NULL
(	NULL
5-CAGAGGGGACTITTC-CGAGA-3	NULL
'	NULL
)	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
3	NULL
of	NULL
the	NULL
mIL-4	NULL
promoter	NULL
-79	NULL
to	NULL
-60	NULL
region	NULL
(	NULL
5-ATAAAATTTGAACATGTAAA-3	NULL
'	NULL
``	NULL
)	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
nondenaturing	NULL
poly-acrylamide	NULL
mini-gel	NULL
at	NULL
80	NULL
V	NULL
for	NULL
75	NULL
min	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Isolation	NULL
and	NULL
Characterization	NULL
of	NULL
a	NULL
Human	NULL
B7.1	NULL
Genomic	NULL
Clone	NULL
.	NULL

To	NULL
isolate	NULL
a	NULL
genomic	NULL
clone	NULL
encoding	NULL
the	NULL
human	NULL
B7.1	NULL
gene	NULL
,	NULL
a	NULL
full-length	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
screen	NULL
a	NULL
leukocyte	NULL
genomic	NULL
DNA	NULL
library	NULL
in	NULL
A	NULL
EMBL-3	NULL
.	NULL

From	NULL
~6	NULL
X	NULL
10°	NULL
plaques	NULL
screened	NULL
,	NULL
10	NULL
clones	NULL
were	NULL
isolated	NULL
that	NULL
remained	NULL
positive	NULL
on	NULL
tertiary	NULL
screening	NULL
.	NULL

These	NULL
clones	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
after	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
and	NULL
hybridization	NULL
with	NULL
*P-labeled	NULL
oligonucleotide	NULL
probes	NULL
corresponding	NULL
to	NULL
sequences	NULL
derived	NULL
from	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
cDNA	NULL
.	NULL

One	NULL
clone	NULL
,	NULL
AUT	NULL
-1	NULL
,	NULL
hybridized	NULL
with	NULL
probes	NULL
from	NULL
the	NULL
first	NULL
two	NULL
exons	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
this	NULL
genomic	NULL
clone	NULL
revealed	NULL
that	NULL
it	NULL
contained	NULL
~14	NULL
kb	NULL
of	NULL
DNA	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
with	NULL
the	NULL
restriction	NULL
map	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

3.9-kb	NULL
of	NULL
DNA	NULL
flanking	NULL
the	NULL
first	NULL
exon	NULL
was	NULL
sequenced	NULL
on	NULL
both	NULL
strands	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
search	NULL
of	NULL
this	NULL
sequence	NULL
using	NULL
FASTA	NULL
of	NULL
the	NULL
GCG	NULL
program	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
alu	NULL
repetitive	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
I	NULL
and	NULL
II	NULL
)	NULL
frequently	NULL
found	NULL
in	NULL
flanking	NULL
regions	NULL
and	NULL
introns	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

No	NULL
other	NULL
significant	NULL
similarities	NULL
betweeen	NULL
the	NULL
hB7.1	NULL
5	NULL
!	NULL

DH	NULL
Site	NULL
B	NULL
DH	NULL
Site	NULL
A	NULL
2	NULL
kb	NULL
CI	NULL
o	NULL
rot	NULL
if	NULL
,	NULL
1	NULL
--	NULL
1	NULL
2	NULL
III	NULL
II	NULL
I	NULL
Figure	NULL
1	NULL
.	NULL

Restriction	NULL
map	NULL
of	NULL
the	NULL
hB7.1	NULL
5	NULL
'	NULL
genomic	NULL
clone	NULL
,	NULL
AUT-1	NULL
.	NULL

(	NULL
Arrows	NULL
)	NULL
Locations	NULL
of	NULL
two	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
,	NULL
A	NULL
and	NULL
B	NULL
.	NULL

(	NULL
Solid	NULL
boxes	NULL
)	NULL
Exons	NULL
1	NULL
and	NULL
2	NULL
.	NULL

Sequences	NULL
similar	NULL
to	NULL
two	NULL
alu	NULL
repeats	NULL
and	NULL
one	NULL
transposon	NULL
element	NULL
,	NULL
Line	NULL
1	NULL
,	NULL
are	NULL
marked	NULL
by	NULL
horizontal	NULL
lines	NULL
and	NULL
are	NULL
designated	NULL
as	NULL
I	NULL
,	NULL
II	NULL
,	NULL
and	NULL
III	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
abbreviations	NULL
of	NULL
restriction	NULL
enzymes	NULL
used	NULL
are	NULL
as	NULL
follow	NULL
:	NULL
BamHI	NULL
(	NULL
B	NULL
)	NULL
,	NULL
EcoRE	NULL
(	NULL
F	NULL
)	NULL
,	NULL
Pacl	NULL
(	NULL
P	NULL
)	NULL
,	NULL
Sacl	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
Xhol	NULL
(	NULL
X	NULL
)	NULL
.	NULL

Pact	NULL
TTAATTAAMARAAAAAGAGTCACAGGCAGG	NULL
AAGAGTAAGATCCCAAGTATAGGAGGAAGA	NULL
GTGTGGTGG	NULL
@	NULL
TTACTAAGAAGACGGCCCTC	NULL
ACTCTGAACGAGGGCTAGCTCTGAAAGICA	NULL
TCCATCTCAAAGAACCAGAAAGAATTGAC	NULL
AGCATTITAAGAGGAMGAGGTGAACTCICC	NULL
CACTTTGATCAGTITGCTGCCAACTTTAGC	NULL
AGCCTGTGGCACTCCTGGGAGCACCATAGC	NULL
CTTAAAGCCTAGATCAGCTECCCTATGATG	NULL
Stut	NULL
B7.1	NULL
Enhancer	NULL
CTTATAGACR	NULL
AGRE	NULL
NF-kB	NULL
Apal	NULL
Sac	NULL
I	NULL
T	NULL
T	NULL
R	NULL
T	NULL
TAGCAC	NULL
CCTGAGTAGGCAACCT	NULL
GCAAATGACAGCACTGAGGCCACTGCCAGG	NULL
AGCCAGCCCAGCCCTCCCTGTGGATGCTGA	NULL
AGCTPTATCAGCATGAGGAGGTGAAGTGGC	NULL
TCCAAGGTCAAGAGCAGAAAGATGGAACCT	NULL
TCATTTCCACAGAGATCATCCTGTTCAGGS	NULL
GTAAAGCAAAGGGCCAGGCTTCCCCTACGG	NULL
TGTCECaACAGCCTCTGCACCAACCTCTGA	NULL
EcoRI	NULL
TCTTCCTGCTGGGTCCTCTACAGTCIGTGA	NULL
TTGTGTTTTCATPTCATPTATAATGTCTTT	NULL
CATTGTACAAATATTTTTAATTTTTATGAA	NULL
TTCAAATCTGTCTATCTPTICITPTPICGP	NULL
TATTTTTAAAA	NULL
GAATTTCTTTTACTTTTATTACAGTAAAGC	NULL
Alu	NULL
II	NULL
CAAGCATCGATTTACAAAAAAATARGTGGC	NULL
ACTAAAGAATTTACACTGAGGAGCAGTAAT	NULL
TCCTGCTTTATTCITCICCAACCCTGG	NULL
@	NULL
TC	NULL
TGCTCCTCAGAACAAACTCATTTAAAGITY	NULL
TITTGITTTGITTIGITTTG	NULL
GGCTTCCAAGTTPTGTGTCITGCTICACCCT	NULL
AGAATTATAAAAATATACTTCATAAATTTA	NULL
TCCTPTCAATTTTTCACATAABAATTTTTA	NULL
AAMGAATITT	NULL
A	NULL
R	NULL
TTICA	NULL
TCA	NULL
anl	NULL
T	NULL
T	NULL
T	NULL
CAA	NULL
CTA	NULL
TCCTTrTAAATCTTITACT	NULL
GTAATATAGGTATTCGGGTTCGGCITCCTT	NULL
TGCCCGTCTTCATCCATCTCACCTICCAGIG	NULL
TCCAGAAATTTACCTTAGAAATCTGTGGTC	NULL
AGCARGAGGAATTAAACACATCCCATTAGT	NULL
ACATAMTCTTGGAAGAGAAGCCTTCTIGAAT	NULL
TTTACAATCAGGATTGGGGAAACTCTGTAA	NULL
AGTACCTTCCTGGTGTTCCTPTCTTCCAGC	NULL
CTCTPTGATTAAGTCACATCAAAGCGCTAA	NULL
TGGCAAAGTTGTTTAATGTGTGTTICICCA	NULL
AGGCAGGTTAGGATTTCACTGGCATTCITA	NULL
AAATTICAGGGTGTCTGTGATCGTCAAAAT	NULL
TPGTATTCATGTAGTCCCTCATGAAATTTC	NULL
TAAAMACTCGGCTGGGTECGeTeceTcaTee	NULL
AXTCTATGTTCCCITTACTTGAAAATGTAA	NULL
TGTTGATCTACTAGAGGTAAGGCAGGAATT	NULL
GTCACATCCATATICCTTGCARCTATTCAA	NULL
AATATGCATCTGAGACCAGAACAAGACACA	NULL
GGTGAAGAAGCGTGCTCACTAGGCCCCTTC	NULL
TGCCAATACAGAAGGAGACAGTGCAGTGCA	NULL
GTCCTTTCATAGCAAGTTCTECCTTCATCA	NULL
TTTCCAAAGCTTCAGTATTCCAAATCTCAG	NULL
GTGAATAGEGTGGTATCCACTAAGCTCTIGC	NULL
CACTRGCTCTCTTTCIGGCIGGTGTGGGAA	NULL
GAGATGGAGTCTTGCTCTGTTACCCAAGCT	NULL
GGATTGTAGTGTTGTCATCICGGCTCACIG	NULL
CAACCCATGCAAGGTGCTGTCAGGTTCCAC	NULL
CTGTECAAACAAGTACACTGGTCCAGCATG	NULL
GGTCAGCTGCTCACTCACAGGGGCTCCAGA	NULL
EcoRI	NULL
ATCCTACAAAGGGACACACAGGGGTEGGTG	NULL
GCAACCTAGTTGGAAATGGGAGTGATGGGC	NULL
ATGACTAAAGTCTTCCTCATCCCACCAGAG	NULL
GCGCACTCAACTGTGGCTAGGGTGACCAGA	NULL
ATTCACTGTCCAGCGTeecTGcacarccce	NULL
ACTCTCTGAAGATCGTGGGATTCAGAGETG	NULL
G	NULL
@	NULL
AGTAGAGTTGGCTGGTCTTGTGAGCTCA	NULL
GCACTCTCCCAAAAGTGTCCCCTACATATG	NULL
AGGTTGACAGCTTATTCCTGCAGGCACTCA	NULL
GGAGTAACTCTGGGTGCTAAAACAAAACTIT	NULL
EcoNL	NULL
GAGACCAGCACAGARACAGCCAGCCCATGA	NULL
AGCTGGCCTCCCATCACACAGCAAGGCTAG	NULL
CCAGMTGCCCCTCACTCTECTCGGGCACCA	NULL
TTCTTCTCCTCCCCTAGGCCECCTGETGCP	NULL
CGTCcTerrTcaTerrTerTaGTCCATGCA	NULL
+	NULL
CGSTG	NULL
@	NULL
TeAGeeaCeCTGCTeTerGaTrI	NULL
CCCCAGCCACAGCCTCTACAAAAGCAAGTA	NULL
GAACAAGACGGCAGCAGAGGGCGCTTCTTC	NULL
AAACACCCTGTCCAACTCCTGGCACTGACA	NULL
AGTACTGAGTCAACTCAAACCCTCTGTAAA	NULL
5°	NULL
untranslated	NULL
region	NULL
GTAACAGAAGTTAGAAGGGGAAATGTCGCC	NULL
TCTCTGAAGATTACCCAAMGAAAMA	NULL
Teat	NULL
TTG	NULL
A	NULL
BamHI	NULL
TTCTTCAGCAAGTAAGTACATTTACTATTA	NULL
TCITACTATGGGATAGCTTGGTAGAACTAG	NULL
TTACCAGCAACCTCACTGCTTTTTAAACAA	NULL
ACAATACCTCTGCTACCACCTCCTGGATCC	NULL
AGGCTTGCCCTCAAMGGAACCCTTAGGGTC	NULL
TCATTCCCACAGGAGGCTGTEGCTTCCCGA	NULL
CATATTTGGAGCATCATAGICAGAATTGTG	NULL
GCCCATTATTTTAARATATCCTAGATCCTA	NULL
GCAAATATTGITTTTGIGGGCCGTATITGA	NULL
ATTTCICAAGCCAGTAAAATICTAGIGAAA	NULL
~3287	NULL
~3137	NULL
-2987	NULL
~2837	NULL
~2687	NULL
~2537	NULL
~2387	NULL
~2237	NULL
-2087	NULL
~1937	NULL
-1787	NULL
~1637	NULL
-1487	NULL
-1337	NULL
-1187	NULL
~1037	NULL
-887	NULL
-137	NULL
-587	NULL
~437	NULL
-287	NULL
~137	NULL
14	NULL
164	NULL
314	NULL
464	NULL
Sact	NULL
GTGGGaaAATCGCTTeAGcTc	NULL
485	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
hB7.1	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
3.9-kb	NULL
Pacl-Sacl	NULL
region	NULL
is	NULL
listed	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
hB7.1	NULL
cDNA	NULL
,	NULL
alu	NULL
repeat	NULL
I	NULL
,	NULL
alu	NULL
repeat	NULL
II	NULL
,	NULL
and	NULL
the	NULL
183-bp	NULL
hB7.1	NULL
enhancer	NULL
are	NULL
underlined	NULL
.	NULL

Representative	NULL
restriction	NULL
endonuclease	NULL
sites	NULL
are	NULL
shown	NULL
and	NULL
the	NULL
putative	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
underlined	NULL
and	NULL
marked	NULL
as	NULL
+1	NULL
.	NULL

These	NULL
sequence	NULL
data	NULL
are	NULL
available	NULL
from	NULL
EMBL/Gen-	NULL
Bank/DDBJ	NULL
under	NULL
accession	NULL
number	NULL
U33208	NULL
.	NULL

flanking	NULL
region	NULL
and	NULL
sequences	NULL
in	NULL
the	NULL
database	NULL
were	NULL
found	NULL
,	NULL
nor	NULL
was	NULL
there	NULL
any	NULL
significant	NULL
similarity	NULL
to	NULL
the	NULL
recently	NULL
published	NULL
mB7.1	NULL
5°	NULL
UT	NULL
region	NULL
.	NULL

Further	NULL
sequencing	NULL
of	NULL
a	NULL
1.3-kb	NULL
BamHI-Pacl	NULL
upstream	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
IIF	NULL
)	NULL
on	NULL
one	NULL
strand	NULL
revealed	NULL
a	NULL
region	NULL
highly	NULL
similar	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
a	NULL
transposon	NULL
element	NULL
,	NULL
line	NULL
1	NULL
,	NULL
commonly	NULL
found	NULL
in	NULL
intergenic	NULL
regions	NULL
of	NULL
chromosomes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

The	NULL
full	NULL
length	NULL
of	NULL
this	NULL
transposon	NULL
is	NULL
~6	NULL
kb	NULL
,	NULL
which	NULL
could	NULL
specify	NULL
two	NULL
transcripts	NULL
in	NULL
the	NULL
same	NULL
transcriptional	NULL
orientation	NULL
as	NULL
hB7.1	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Two	NULL
consensus	NULL
TATAA	NULL
elements	NULL
were	NULL
present	NULL
at	NULL
positions	NULL
-2608	NULL
and	NULL
-2501	NULL
relative	NULL
to	NULL
the	NULL
putative	NULL
transcription	NULL
start	NULL
site	NULL
without	NULL
neighboring	NULL
5	NULL
consensus	NULL
CCAAT	NULL
motifs	NULL
.	NULL

No	NULL
TATAA	NULL
or	NULL
initiator	NULL
sequences	NULL
were	NULL
present	NULL
down-stream	NULL
.	NULL

B7.1	NULL
Expression	NULL
Correlates	NULL
with	NULL
the	NULL
Presence	NULL
of	NULL
a	NULL
DNase	NULL
I	NULL
Hypersensitive	NULL
Site	NULL
in	NULL
Cultured	NULL
Cell	NULL
Lines	NULL
.	NULL

As	NULL
an	NULL
initial	NULL
approach	NULL
to	NULL
identify	NULL
tissue-specific	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
hB7.1	NULL
gene	NULL
,	NULL
the	NULL
chromatin	NULL
configuration	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
examined	NULL
in	NULL
intact	NULL
nuclei	NULL
from	NULL
various	NULL
cell	NULL
types	NULL
by	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
assays	NULL
.	NULL

Nuclei	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
cultured	NULL
human	NULL
lines	NULL
were	NULL
isolated	NULL
and	NULL
digested	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
DNase	NULL
I	NULL
.	NULL

The	NULL
purified	NULL
DNA	NULL
was	NULL
then	NULL
digested	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
endonuclease	NULL
(	NULL
Xhol	NULL
,	NULL
BamHI	NULL
,	NULL
or	NULL
SacI	NULL
)	NULL
,	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
295-bp	NULL
Scal-BamHI	NULL
probe	NULL
spanning	NULL
the	NULL
first	NULL
exon	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
were	NULL
780	NULL
Regulation	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
examined	NULL
simultaneously	NULL
by	NULL
FACS®	NULL
analysis	NULL
for	NULL
surface	NULL
B7.1	NULL
expression	NULL
using	NULL
the	NULL
anti-hB7.1	NULL
mAb	NULL
133	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig.3	NULL
A	NULL
,	NULL
Xhol	NULL
digestion	NULL
of	NULL
nuclear	NULL
DNA	NULL
gives	NULL
the	NULL
expected	NULL
single	NULL
9.5-kb	NULL
restriction	NULL
fragment	NULL
.	NULL

Treatment	NULL
of	NULL
nuclear	NULL
DNA	NULL
from	NULL
all	NULL
cell	NULL
lines	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase	NULL
I	NULL
results	NULL
in	NULL
the	NULL
progressive	NULL
disappearance	NULL
of	NULL
the	NULL
full-length	NULL
fragment	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
either	NULL
one	NULL
or	NULL
two	NULL
nuclease-generated	NULL
subfragments	NULL
of	NULL
~1.7	NULL
(	NULL
DH	NULL
site	NULL
A	NULL
)	NULL
and	NULL
4.6	NULL
kb	NULL
(	NULL
DH	NULL
site	NULL
B	NULL
.	NULL
)	NULL

.	NULL

Since	NULL
the	NULL
1.7-kb	NULL
subfragment	NULL
was	NULL
present	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
this	NULL
new	NULL
band	NULL
represents	NULL
a	NULL
non-tissue-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
.	NULL

However	NULL
,	NULL
the	NULL
second	NULL
4.6-kb	NULL
nuclease-generated	NULL
subfragment	NULL
appeared	NULL
only	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
surface	NULL
B7.1	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
fragments	NULL
are	NULL
present	NULL
in	NULL
the	NULL
EBV5	NULL
,	NULL
SKW	NULL
,	NULL
and	NULL
Raji	NULL
B7.1-positive	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
remaining	NULL
B7.1-negative	NULL
cells	NULL
(	NULL
Jurkat	NULL
T	NULL
cell	NULL
,	NULL
fibroblast	NULL
and	NULL
carcinoma	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
pre-B	NULL
cell	NULL
lines	NULL
)	NULL
have	NULL
only	NULL
the	NULL
1.7-kb	NULL
subfragment	NULL
.	NULL

In	NULL
only	NULL
a	NULL
single	NULL
case	NULL
,	NULL
namely	NULL
the	NULL
BL3O	NULL
B	NULL
cell	NULL
,	NULL
did	NULL
a	NULL
B7.1-positive	NULL
line	NULL
fail	NULL
to	NULL
generate	NULL
the	NULL
4.6-kb	NULL
DH	NULL
site	NULL
B	NULL
subfragment	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
unique	NULL
factors	NULL
interact	NULL
with	NULL
other	NULL
elements	NULL
in	NULL
this	NULL
transformed	NULL
cell	NULL
line	NULL
to	NULL
control	NULL
B7.1	NULL
expression	NULL
.	NULL

Indeed	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
BL30	NULL
cell	NULL
line	NULL
with	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
enhancer	NULL
region	NULL
represented	NULL
by	NULL
DH	NULL
site	NULL
B	NULL
(	NULL
described	NULL
below	NULL
)	NULL
revealed	NULL
an	NULL
absence	NULL
of	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Aside	NULL
from	NULL
this	NULL
one	NULL
cell	NULL
line	NULL
,	NULL
Table	NULL
1	NULL
.	NULL

-	NULL
Summary	NULL
of	NULL
the	NULL
Correlation	NULL
between	NULL
Surface	NULL
B7.1	NULL
Expression	NULL
and	NULL
Tissue-specific	NULL
DNase	NULL
I	NULL
Hypersensitive	NULL
Site	NULL
B	NULL
Surface	NULL
Cell	NULL
line	NULL
B7.1	NULL
-	NULL
DH	NULL
Site	NULL
B	NULL
Pre-B	NULL
Nalm6	NULL
-	NULL
Ramos	NULL
~-	NULL
B	NULL
BL30	NULL
+	NULL
EBV5	NULL
+	NULL
+	NULL
Raji	NULL
+	NULL
+	NULL
SKW	NULL
+	NULL
+	NULL
T	NULL
Jurkat	NULL
-	NULL
Fibroblast	NULL
GM00637	NULL
Epitheloid	NULL
carcinoma	NULL
HeLa	NULL
-	NULL
Hepatocellular	NULL
carcinoma	NULL
HepG2	NULL
-	NULL
Small	NULL
cell	NULL
lung	NULL
carcinoma	NULL
NCI-H146	NULL
-	NULL
Surface	NULL
expression	NULL
of	NULL
B7.1	NULL
on	NULL
a	NULL
panel	NULL
of	NULL
human	NULL
lymphoid	NULL
and	NULL
nonlym-phoid	NULL
cell	NULL
lines	NULL
was	NULL
determined	NULL
by	NULL
FACS®	NULL
analysis	NULL
using	NULL
anti-hB7.1	NULL
mAb	NULL
133	NULL
.	NULL

Presence	NULL
or	NULL
absence	NULL
of	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
B	NULL
in	NULL
the	NULL
hB7.1	NULL
5¢	NULL
flanking	NULL
region	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
determined	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
and	NULL
listed	NULL
as	NULL
+	NULL
or	NULL
-	NULL
,	NULL
respectively	NULL
.	NULL

however	NULL
,	NULL
DH	NULL
site	NULL
B	NULL
appears	NULL
to	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
B7	NULL
.	NULL

1	NULL
gene	NULL
.	NULL

To	NULL
map	NULL
the	NULL
location	NULL
of	NULL
the	NULL
two	NULL
DH	NULL
sites	NULL
more	NULL
precisely	NULL
,	NULL
nuclear	NULL
DNA	NULL
from	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
was	NULL
digested	NULL
with	NULL
additional	NULL
restriction	NULL
endonucleases	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
same	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
assays	NULL
.	NULL

Digestion	NULL
with	NULL
BamHI	NULL
revealed	NULL
that	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
are	NULL
~0.3	NULL
and	NULL
3.2	NULL
kb	NULL
,	NULL
respectively	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
BamHI	NULL
site	NULL
located	NULL
3	NULL
'	NULL
to	NULL
exon	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

DH	NULL
site	NULL
A	NULL
,	NULL
therefore	NULL
,	NULL
is	NULL
located	NULL
very	NULL
near	NULL
the	NULL
putative	NULL
transcription	NULL
start	NULL
site	NULL
mapped	NULL
previously	NULL
by	NULL
primer	NULL
extension	NULL
.	NULL

Digestion	NULL
of	NULL
DNase	NULL
I-treated	NULL
Raji	NULL
nuclear	NULL
DNA	NULL
with	NULL
Sacl	NULL
revealed	NULL
a	NULL
single	NULL
0.6-kb	NULL
fragment	NULL
representing	NULL
site	NULL
A	NULL
.	NULL

Since	NULL
site	NULL
B	NULL
is	NULL
not	NULL
included	NULL
in	NULL
the	NULL
Sacl	NULL
fragment	NULL
,	NULL
it	NULL
can	NULL
be	NULL
mapped	NULL
between	NULL
the	NULL
upstream	NULL
BamHI	NULL
and	NULL
Sacl	NULL
sites	NULL
to	NULL
a	NULL
location	NULL
~100	NULL
bp	NULL
5	NULL
``	NULL
to	NULL
the	NULL
Sacl	NULL
site	NULL
,	NULL
~3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
putative	NULL
start	NULL
site	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
two	NULL
DH	NULL
sites	NULL
is	NULL
shown	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
C.	NULL
Localization	NULL
of	NULL
a	NULL
Transcriptional	NULL
Enhancer	NULL
at	NULL
DH	NULL
Site	NULL
B	NULL
.	NULL

-	NULL
'The	NULL
3.3-kb	NULL
Sacl	NULL
fragment	NULL
which	NULL
includes	NULL
DH	NULL
site	NULL
A	NULL
did	NULL
not	NULL
have	NULL
transcriptional	NULL
activity	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

It	NULL
was	NULL
possible	NULL
that	NULL
negative	NULL
regulatory	NULL
elements	NULL
within	NULL
this	NULL
region	NULL
were	NULL
responsible	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
DH	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
represented	NULL
B7.1	NULL
enhancer	NULL
elements	NULL
,	NULL
we	NULL
therefore	NULL
subcloned	NULL
a	NULL
variety	NULL
of	NULL
fragments	NULL
encompassing	NULL
one	NULL
or	NULL
both	NULL
of	NULL
these	NULL
sites	NULL
into	NULL
pSyncatll	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
a	NULL
minimal	NULL
herpes	NULL
virus	NULL
tk	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

Fragments	NULL
tested	NULL
in	NULL
preliminary	NULL
experiments	NULL
included	NULL
a	NULL
large	NULL
5-kb	NULL
BamHI	NULL
fragment	NULL
containing	NULL
both	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
and	NULL
a	NULL
smaller	NULL
2.8-kb	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
only	NULL
site	NULL
B	NULL
.	NULL

The	NULL
former	NULL
had	NULL
minimal	NULL
activity	NULL
whereas	NULL
the	NULL
latter	NULL
gave	NULL
a	NULL
threefold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
over	NULL
the	NULL
vector	NULL
alone	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
3.7-kb	NULL
Pacl-BamHI	NULL
fragment	NULL
which	NULL
included	NULL
both	NULL
DH	NULL
sites	NULL
was	NULL
also	NULL
inactive	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

A	NULL
Jurkat	NULL
EBVS	NULL
SKW	NULL
BL3O	NULL
GMO0637	NULL
HeLa	NULL
``	NULL
o	NULL
-	NULL
(	NULL
Wl	NULL
jig	NULL
s	NULL
MB	NULL
+a	NULL
e	NULL
'	NULL
a	NULL
£4	NULL
~	NULL
80	NULL
24	NULL
>	NULL
-s	NULL
J-	NULL
§§	NULL
sq	NULL
6.6	NULL
-	NULL
t	NULL
¥	NULL
Fs	NULL
._	NULL
U8	NULL
(	NULL
w	NULL
+	NULL
--	NULL
DH	NULL
44	NULL
site	NULL
B	NULL
2.3	NULL
2.0	NULL
~	NULL
``	NULL
*	NULL
4	NULL
t*	NULL
--	NULL
DH	NULL
site	NULL
A	NULL
past	NULL
0	NULL
8	NULL
16	NULL
=	NULL
0	NULL
s	NULL
i6	NULL
=	NULL
0	NULL
8	NULL
16	NULL
f	NULL
;	NULL
1	NULL
{	NULL
ug/imi	NULL
)	NULL
:	NULL
O0	NULL
8	NULL
16	NULL
0	NULL
8	NULL
16	NULL
0	NULL
s	NULL
i6	NULL
B	NULL
Raji	NULL
C	NULL
DH	NULL
SiteB	NULL
_	NULL
DH	NULL
SiteA	NULL
BamHI	NULL
Sac	NULL
|	NULL
X	NULL
8	NULL
8	NULL
BS	NULL
x	NULL
Digestion	NULL
Digestion	NULL
!	NULL

|	NULL
L	NULL
lg	NULL
}	NULL
1	NULL
lﬂw	NULL
soe	NULL
Kb	NULL
{	NULL
gig-hp	NULL
6.6	NULL
-	NULL
DNasel	NULL
+	NULL
Xhol	NULL
Digestion	NULL
4.4	NULL
J	NULL
.	NULL

”	NULL
*t3	NULL
__	NULL
Xhot	NULL
a.5kb	NULL
QEH+2T95	NULL
‘	NULL
I-	NULL
on	NULL
SteB	NULL
46k	NULL
-	NULL
Figure	NULL
3	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitive	NULL
analysis	NULL
of	NULL
23	NULL
-	NULL
}	NULL
--	NULL
onSiteA	NULL
17k	NULL
-	NULL
the	NULL
hB7.1	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Nontissue-2.0	NULL
~	NULL
DNase	NULL
!	NULL

+	NULL
BamHI	NULL
Digestion	NULL
specific	NULL
DH	NULL
site	NULL
A	NULL
and	NULL
tissue-specific	NULL
site	NULL
B	NULL
are	NULL
BamkHI	NULL
Bambi	NULL
shown	NULL
in	NULL
Southern	NULL
blot	NULL
analysis	NULL
with	NULL
Xhol-di-0.702	NULL
-	NULL
*	NULL
°°	NULL
_	NULL
gested	NULL
DNAs	NULL
from	NULL
both	NULL
B7.1+*	NULL
and	NULL
B7.1~	NULL
cell	NULL
a	NULL
=	NULL
PH	NULL
r	NULL
~	NULL
°	NULL
g	NULL
:	NULL
its	NULL
?	NULL

323	NULL
t	NULL
:	NULL
lines	NULL
and	NULL
(	NULL
B	NULL
)	NULL
with	NULL
BamHI-	NULL
or	NULL
Sacl-digested	NULL
0.224	NULL
-	NULL
C	NULL
{	NULL
Raji	NULL
DNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
schematic	NULL
presentation	NULL
of	NULL
DNase	NULL
I	NULL
I+	NULL
igesti	NULL
DH	NULL
site	NULL
A	NULL
and	NULL
B	NULL
locations	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
re-	NULL
(	NULL
ugiml	NULL
:	NULL
0	NULL
13	NULL
0	NULL
13	NULL
DNasel	NULL
+	NULL
Sacl	NULL
Digestion	NULL
Sac	NULL
Sac	NULL
€	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

gion	NULL
,	NULL
derived	NULL
from	NULL
three	NULL
different	NULL
restriction	NULL
di-gestions	NULL
.	NULL

3.3	NULL
kb	NULL
DH	NULL
Site	NULL
A	NULL
0.6	NULL
kb	NULL
-s	NULL
A	NULL
OH	NULL
$	NULL
“	NULL
B	NULL
DH	NULL
Sto	NULL
A	NULL
Lano	NULL
-	NULL
Plasmid	NULL
e	NULL
se	NULL
p	NULL
she	NULL
50,9	NULL
1	NULL
pSyncatll	NULL
!	NULL

2	NULL
1.9	NULL
kb	NULL
BamHI-Saci	NULL
«	NULL
3	NULL
1.3	NULL
kb	NULL
Spet-Saci	NULL
___	NULL
a	NULL
D2	NULL
cd	NULL
4	NULL
585	NULL
bp	NULL
Pacl-Saci	NULL
5	NULL
-	NULL
282	NULL
bp	NULL
Stul-Sacl	NULL
cl	NULL
c	NULL
c	NULL
&	NULL
6	NULL
95	NULL
bp	NULL
Apal-Saci	NULL
7	NULL
486	NULL
bp	NULL
Pacl-Apal	NULL
f	NULL
cz	NULL
22	NULL
.	NULL

8	NULL
-	NULL
303	NULL
bp	NULL
Pacl-Stul	NULL
9	NULL
183	NULL
bp	NULL
Stul-Apal	NULL
wa	NULL
2	NULL
2	NULL
2	NULL
2	NULL
o	NULL
uaf	NULL
10	NULL
585	NULL
bp	NULL
Pacl-Saci	NULL
reverse	NULL
22222	NULL
22	NULL
2	NULL
2	NULL
11	NULL
282	NULL
bp	NULL
Stul	NULL
reverse	NULL
C	NULL
468	NULL
bp	NULL
EcoNl-BamHI	NULL
12	NULL
-	NULL
3.7	NULL
kb	NULL
Pact-BamkHI	NULL
_-	NULL
-s	NULL
B	NULL
DH	NULL
See	NULL
B	NULL
.	NULL

..	NULL
OH	NULL
SteA	NULL
p	NULL
5	NULL
+	NULL
cot	NULL
w	NULL
's	NULL
Relative	NULL
CAT	NULL
Activity	NULL
St	NULL
AS	NULL
:	NULL
$	NULL
o	NULL
an	NULL
Lane	NULL
-	NULL
Plasmid	NULL
£04	NULL
64g	NULL
gpa	NULL
0	NULL
5	NULL
10	NULL
15	NULL
_	NULL
20	NULL
ne	NULL
F	NULL
'd	NULL
_	NULL
i-	NULL
``	NULL
|	NULL
1	NULL
-	NULL
pSyncatl	NULL
(	NULL
taza	NULL
)	NULL
I	NULL
|	NULL
2	NULL
-	NULL
9.7	NULL
kb	NULL
Pacl-BamHI	NULL
«	NULL
A	NULL
'	NULL
-GAD	NULL
F	NULL
|	NULL
3	NULL
-	NULL
486	NULL
bp	NULL
Pacl-Apal	NULL
i	NULL
i	NULL
_	NULL
-	NULL
(	NULL
ear	NULL
.	NULL

4	NULL
_	NULL
468	NULL
bp	NULL
EcoNl-BamHI	NULL
--	NULL
I	NULL
|	NULL
s	NULL
ago	NULL
be	NULL
,	NULL
.	NULL

-	NULL
0	NULL
--	NULL
|	NULL
A	NULL
series	NULL
of	NULL
restriction	NULL
endonuclease-generated	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
deletion	NULL
fragments	NULL
were	NULL
therefore	NULL
constructed	NULL
and	NULL
tested	NULL
for	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

The	NULL
1.9-kb	NULL
BamHI-Sacl	NULL
fragment	NULL
displayed	NULL
fivefold	NULL
activity	NULL
above	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
further	NULL
deletions	NULL
of	NULL
this	NULL
fragment	NULL
from	NULL
the	NULL
5°	NULL
end	NULL
resulted	NULL
in	NULL
increasing	NULL
levels	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

A	NULL
further	NULL
deletion	NULL
to	NULL
the	NULL
Apal	NULL
site	NULL
deleted	NULL
DH	NULL
site	NULL
B	NULL
and	NULL
abolished	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
thus	NULL
establishing	NULL
the	NULL
5	NULL
border	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

Similarly	NULL
,	NULL
deletions	NULL
from	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
active	NULL
486-bp	NULL
Pacl-Apal	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
to	NULL
the	NULL
Stul	NULL
site	NULL
183	NULL
bp	NULL
upstream	NULL
abolished	NULL
activity	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
localize	NULL
the	NULL
enhancer	NULL
to	NULL
a	NULL
183-bp	NULL
Stul-Apal	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
which	NULL
is	NULL
active	NULL
in	NULL
both	NULL
forward	NULL
and	NULL
reverse	NULL
orientations	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
11	NULL
and	NULL
4	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Multiple	NULL
constructs	NULL
which	NULL
included	NULL
the	NULL
region	NULL
surrounding	NULL
DH	NULL
site	NULL
A	NULL
failed	NULL
to	NULL
provide	NULL
evidence	NULL
for	NULL
enhancer	NULL
function	NULL
in	NULL
this	NULL
location	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
hB7.1	NULL
gene	NULL
had	NULL
been	NULL
mapped	NULL
by	NULL
primer	NULL
extension	NULL
to	NULL
a	NULL
site	NULL
58	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
cDNA	NULL
sequence	NULL
(	NULL
31	NULL
)	NULL
,	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
were	NULL
tested	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
5-kb	NULL
BamHI	NULL
fragment	NULL
and	NULL
a	NULL
3.3-kb	NULL
Sacl	NULL
fragment	NULL
containing	NULL
the	NULL
first	NULL
exon	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
promoterless	NULL
pSyncatl	NULL
expression	NULL
vector	NULL
.	NULL

Deletion	NULL
variants	NULL
of	NULL
the	NULL
latter	NULL
construct	NULL
generated	NULL
by	NULL
restriction	NULL
enzyme	NULL
di-gestion	NULL
,	NULL
ranging	NULL
from	NULL
~0.5	NULL
to	NULL
2	NULL
kb	NULL
of	NULL
upstream	NULL
sequence	NULL
were	NULL
also	NULL
produced	NULL
.	NULL

This	NULL
series	NULL
of	NULL
constructs	NULL
was	NULL
tested	NULL
for	NULL
promoter	NULL
activity	NULL
by	NULL
transfection	NULL
into	NULL
the	NULL
B7.1-positive	NULL
Raji	NULL
B	NULL
lymphoma	NULL
cell	NULL
line	NULL
.	NULL

However	NULL
,	NULL
in	NULL
preliminary	NULL
ex-periments	NULL
,	NULL
no	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
detected	NULL
.	NULL

Since	NULL
782	NULL
Regulation	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
Figure	NULL
4.	NULL
hB7.1	NULL
enhancer	NULL
activity	NULL
in	NULL
transfected	NULL
Raji	NULL
cells	NULL
.	NULL

(	NULL
Solid	NULL
lines	NULL
)	NULL
The	NULL
5°	NULL
flanking	NULL
region	NULL
clone	NULL
and	NULL
its	NULL
deletion	NULL
variants	NULL
used	NULL
for	NULL
transfection	NULL
.	NULL

Each	NULL
clone	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
size	NULL
of	NULL
restriction	NULL
fragment	NULL
listed	NULL
and	NULL
only	NULL
part	NULL
of	NULL
the	NULL
length	NULL
between	NULL
the	NULL
EcoRI	NULL
site	NULL
and	NULL
exon	NULL
1	NULL
(	NULL
black	NULL
box	NULL
)	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
abbreviation	NULL
of	NULL
restriction	NULL
enzymes	NULL
used	NULL
are	NULL
Apal	NULL
(	NULL
4	NULL
)	NULL
,	NULL
BamHI	NULL
(	NULL
B	NULL
)	NULL
,	NULL
EcoRI	NULL
(	NULL
E	NULL
)	NULL
,	NULL
EcoNI	NULL
(	NULL
EN	NULL
)	NULL
,	NULL
Pacl	NULL
(	NULL
P	NULL
)	NULL
,	NULL
Sacl	NULL
(	NULL
S	NULL
)	NULL
,	NULL
Spel	NULL
(	NULL
Sp	NULL
)	NULL
,	NULL
and	NULL
Stul	NULL
(	NULL
St	NULL
)	NULL
.	NULL

Enhancer	NULL
activity	NULL
is	NULL
shown	NULL
either	NULL
with	NULL
a	NULL
heterologous	NULL
tk	NULL
promoter	NULL
(	NULL
4	NULL
)	NULL
or	NULL
with	NULL
the	NULL
homologous	NULL
promoter	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
pug	NULL
of	NULL
each	NULL
plasmid	NULL
DNA	NULL
.	NULL

One	NULL
representative	NULL
CAT	NULL
assay	NULL
experiment	NULL
is	NULL
shown	NULL
in	NULL
A	NULL
.	NULL

The	NULL
relative	NULL
CAT	NULL
activity	NULL
of	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
in	NULL
A	NULL
and	NULL
lanes	NULL
1-5	NULL
in	NULL
B	NULL
are	NULL
calculated	NULL
based	NULL
on	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

the	NULL
failure	NULL
to	NULL
detect	NULL
promoter	NULL
activity	NULL
might	NULL
reflect	NULL
the	NULL
presence	NULL
of	NULL
dominant	NULL
negative	NULL
regulatory	NULL
elements	NULL
,	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
486-bp	NULL
enhancer	NULL
upstream	NULL
of	NULL
a	NULL
468-bp	NULL
EcoNI-BamHI	NULL
fragment	NULL
including	NULL
DH	NULL
site	NULL
A	NULL
in	NULL
place	NULL
of	NULL
the	NULL
heterologous	NULL
tk	NULL
promoter	NULL
was	NULL
made	NULL
.	NULL

This	NULL
construct	NULL
conferred	NULL
transcription	NULL
activity	NULL
,	NULL
thus	NULL
demonstrating	NULL
that	NULL
sequences	NULL
surrounding	NULL
DH	NULL
site	NULL
A	NULL
can	NULL
act	NULL
as	NULL
a	NULL
minimal	NULL
promoter	NULL
.	NULL

Neither	NULL
the	NULL
468-bp	NULL
promoter	NULL
fragment	NULL
nor	NULL
the	NULL
486-bp	NULL
enhancer	NULL
alone	NULL
were	NULL
active	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
transcriptional	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
longer	NULL
promoter	NULL
fragments	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
negative	NULL
regulatory	NULL
elements	NULL
downstream	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
possibly	NULL
including	NULL
the	NULL
alu	NULL
repeat	NULL
sequences	NULL
.	NULL

Indeed	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
alu	NULL
sequences	NULL
increases	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
B7.1	NULL
promoter	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
transcriptionally	NULL
active	NULL
and	NULL
to	NULL
contain	NULL
six	NULL
elements	NULL
within	NULL
the	NULL
first	NULL
150	NULL
bp	NULL
of	NULL
the	NULL
promoter	NULL
that	NULL
are	NULL
bound	NULL
by	NULL
nuclear	NULL
proteins	NULL
;	NULL
one	NULL
of	NULL
them	NULL
is	NULL
NF-KB	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
B7.1	NULL
Enhancer	NULL
is	NULL
Cell	NULL
Type	NULL
Specific	NULL
and	NULL
Inducible	NULL
by	NULL
cAMP	NULL
and	NULL
LPS	NULL
.	NULL

-	NULL
B7.1	NULL
expression	NULL
is	NULL
strictly	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

To	NULL
test	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
enhancer	NULL
region	NULL
defined	NULL
above	NULL
,	NULL
transient	NULL
transfections	NULL
of	NULL
several	NULL
constructs	NULL
which	NULL
include	NULL
this	NULL
region	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
tested	NULL
included	NULL
the	NULL
B7.1-negative	NULL
Jurkat	NULL
T	NULL
lymphoma	NULL
and	NULL
Hela	NULL
epithelial	NULL
carcinoma	NULL
and	NULL
the	NULL
B7.1-positive	NULL
human	NULL
B	NULL
Lymphoma	NULL
BA	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
585-	NULL
,	NULL
282-	NULL
,	NULL
and	NULL
183-bp	NULL
constructs	NULL
shown	NULL
to	NULL
be	NULL
active	NULL
in	NULL
the	NULL
B7.1-positve	NULL
Raji	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
are	NULL
also	NULL
active	NULL
in	NULL
the	NULL
BA	NULL
cells	NULL
.	NULL

No	NULL
enhancer	NULL
activity	NULL
from	NULL
any	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
Jurkat	NULL
or	NULL
HeLa	NULL
cell	NULL
lines	NULL
,	NULL
demonstrating	NULL
that	NULL
,	NULL
in	NULL
non-B	NULL
Relative	NULL
CAT	NULL
Activity	NULL
Relative	NULL
CAT	NULL
Activity	NULL
Relative	NULL
CAT	NULL
Activity	NULL
Hela	NULL
Jurkat	NULL
107	NULL
J	NULL
8A	NULL
5-o	NULL
ES	NULL
U	NULL
I	NULL
pSyncatll	NULL
3	NULL
.	NULL

7	NULL
kb	NULL
585	NULL
bp	NULL
183	NULL
bp	NULL
282	NULL
bp	NULL
Pack-BamHI	NULL
-	NULL
Pack	NULL
Sacl	NULL
Stul-Sacl	NULL
_	NULL
Stul-Sact	NULL
reverse	NULL
15	NULL
(	NULL
M12-cAMP	NULL
N	NULL
Mi2+cAMP	NULL
104	NULL
5-pSyncatll	NULL
3.7	NULL
kb	NULL
585	NULL
bp	NULL
183	NULL
bp	NULL
282	NULL
bp	NULL
Pack-BamHI	NULL
-	NULL
Pacl-Sacl	NULL
-	NULL
Stul-Sacl	NULL
Stul-Sacl	NULL
reverse	NULL
125	NULL
C	NULL
«	NULL
rs	NULL
10.0	NULL
.	NULL

ALPS	NULL
€	NULL
Control	NULL
a	NULL
LPS	NULL
g	NULL
f	NULL
7.5|	NULL
--	NULL
1G10	NULL
5	NULL
£	NULL
sol-__iG10+	NULL
LPS	NULL
S	NULL
&	NULL
0	NULL
pSyncatH	NULL
585bp	NULL
183	NULL
bp	NULL
Pacl-Secl	NULL
-	NULL
Stul-	NULL
Sacl	NULL
40	NULL
F	NULL
]	NULL
mairs	NULL
N	NULL
mers	NULL
I	NULL
30	NULL
-	NULL
‘	NULL
I	NULL
'	NULL
20	NULL
107	NULL
0	NULL
e	NULL
oul	NULL
zs	NULL
__|	NULL
ee	NULL
_I	NULL
pSyncat	NULL
!	NULL

468	NULL
bp	NULL
486	NULL
bp	NULL
pSyncatll	NULL
183	NULL
bp	NULL
EcoNi-BamHI	NULL
Paci-Apal	NULL
Stui-Apal	NULL
B7.1	NULL
promoter	NULL
/468	NULL
bp	NULL
B7.1	NULL
enhancer	NULL
EcoNl-BamHI	NULL
/tk	NULL
promoter	NULL
B7.1	NULL
enhancer	NULL
promoter	NULL
783	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

cells	NULL
,	NULL
this	NULL
183-bp	NULL
region	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

Additional	NULL
B7.1-negative	NULL
cell	NULL
lines	NULL
(	NULL
Hut78	NULL
T	NULL
cell	NULL
and	NULL
G82	NULL
glioblas-toma	NULL
)	NULL
also	NULL
showed	NULL
no	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Some	NULL
modest	NULL
(	NULL
about	NULL
twofold	NULL
)	NULL
enhancer	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
B7.1-negative	NULL
pre-B	NULL
cell	NULL
line	NULL
Nalm	NULL
6	NULL
with	NULL
these	NULL
constructs	NULL
,	NULL
but	NULL
no	NULL
activity	NULL
was	NULL
present	NULL
when	NULL
the	NULL
longer	NULL
1.3-	NULL
,	NULL
1.9-	NULL
,	NULL
and	NULL
3.7-kb	NULL
constructs	NULL
were	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
in	NULL
B7.1-negative	NULL
B	NULL
cells	NULL
,	NULL
there	NULL
may	NULL
also	NULL
be	NULL
a	NULL
role	NULL
for	NULL
negative	NULL
elements	NULL
,	NULL
outside	NULL
of	NULL
the	NULL
183-bp	NULL
enhancer	NULL
,	NULL
in	NULL
mediating	NULL
tissue	NULL
specificity	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
enhancer	NULL
located	NULL
at	NULL
DH	NULL
site	NULL
B	NULL
within	NULL
the	NULL
183-bp	NULL
Stul-Apal	NULL
fragment	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

Multiple	NULL
stimuli	NULL
increase	NULL
B7.1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
M12	NULL
cell	NULL
line	NULL
expresses	NULL
low	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
B7.1	NULL
that	NULL
can	NULL
be	NULL
markedly	NULL
increased	NULL
by	NULL
treatment	NULL
with	NULL
db-cAMP	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
M12	NULL
with	NULL
30	NULL
pg/ml	NULL
db-cAMP	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
585-	NULL
,	NULL
282-	NULL
,	NULL
and	NULL
183-bp	NULL
constructs	NULL
results	NULL
in	NULL
a	NULL
modest	NULL
but	NULL
reproducible	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

We	NULL
were	NULL
also	NULL
able	NULL
to	NULL
test	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
by	NULL
LPS	NULL
in	NULL
both	NULL
M12	NULL
and	NULL
in	NULL
the	NULL
mouse	NULL
B7.1-positive	NULL
myeloblast/monocyte-like	NULL
cell	NULL
line	NULL
M1	NULL
.	NULL

Treatment	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
with	NULL
LPS	NULL
for	NULL
48	NULL
h	NULL
results	NULL
in	NULL
a	NULL
modest	NULL
but	NULL
reproducible	NULL
increase	NULL
in	NULL
both	NULL
surface	NULL
B7.1	NULL
expression	NULL
for	NULL
M1	NULL
(	NULL
not	NULL
tested	NULL
for	NULL
M12	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
,	NULL
leff	NULL
)	NULL
and	NULL
CAT	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
5	NULL
C	NULL
,	NULL
right	NULL
and	NULL
Fig.5	NULL
D	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
native	NULL
B7.1	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
486-bp	NULL
enhancer	NULL
in	NULL
the	NULL
M12	NULL
cell	NULL
line	NULL
.	NULL

Induction	NULL
of	NULL
transcription	NULL
by	NULL
LPS	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
this	NULL
instance	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
D	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
elements	NULL
within	NULL
the	NULL
183-bp	NULL
region	NULL
confer	NULL
responsiveness	NULL
to	NULL
stimuli	NULL
known	NULL
to	NULL
increase	NULL
B7.1	NULL
expression	NULL
.	NULL

Further	NULL
,	NULL
enhancer	NULL
activity	NULL
is	NULL
not	NULL
limited	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
B	NULL
lineage	NULL
,	NULL
but	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
B7.1-positive	NULL
,	NULL
non-B	NULL
cells	NULL
,	NULL
including	NULL
the	NULL
HTLV-1-transformed	NULL
B7.1-positive	NULL
T	NULL
cell	NULL
MT2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
could	NULL
not	NULL
examine	NULL
other	NULL
stimuli	NULL
such	NULL
as	NULL
IL-4	NULL
or	NULL
Abs	NULL
to	NULL
CD40	NULL
,	NULL
known	NULL
to	NULL
induce	NULL
B7.1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
because	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
appropriately	NULL
inducible	NULL
,	NULL
transfectable	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
this	NULL
enhancer	NULL
region	NULL
also	NULL
controls	NULL
responsiveness	NULL
to	NULL
other	NULL
stimuli	NULL
such	NULL
as	NULL
IL-4	NULL
and	NULL
anti-CD40	NULL
may	NULL
require	NULL
the	NULL
production	NULL
of	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
enhancer	NULL
to	NULL
allow	NULL
the	NULL
examination	NULL
of	NULL
B7.1	NULL
regulation	NULL
in	NULL
normal	NULL
cells	NULL
.	NULL

Deletional	NULL
and	NULL
Mutational	NULL
Analysis	NULL
of	NULL
the	NULL
183-bp	NULL
Enhancer	NULL
Reveals	NULL
Several	NULL
Functional	NULL
cis	NULL
Elements	NULL
.	NULL

-	NULL
Initial	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
employing	NULL
a	NULL
series	NULL
of	NULL
enhancer	NULL
deletion	NULL
constructs	NULL
with	NULL
subsequent	NULL
transfection	NULL
into	NULL
Raji	NULL
cells	NULL
revealed	NULL
that	NULL
nucle-	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Tissue-specific	NULL
hB7.1	NULL
enhancer	NULL
activity	NULL
in	NULL
transfected	NULL
B	NULL
and	NULL
non-B	NULL
cells	NULL
and	NULL
induction	NULL
by	NULL
db-cAMP	NULL
and	NULL
LPS	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Selected	NULL
clones	NULL
of	NULL
the	NULL
hB7.1	NULL
5¢	NULL
flanking	NULL
region	NULL
and	NULL
its	NULL
deletion	NULL
variants	NULL
were	NULL
transfected	NULL
into	NULL
B7.1-positive	NULL
or	NULL
-negative	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfected	NULL
M12	NULL
cells	NULL
were	NULL
either	NULL
induced	NULL
or	NULL
uninduced	NULL
with	NULL
30	NULL
jg/ml	NULL
db-cAMP	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Enhancer	NULL
activity	NULL
in	NULL
murine	NULL
myeloid	NULL
M1	NULL
cells	NULL
and	NULL
inducibility	NULL
by	NULL
LPS	NULL
.	NULL

FACS®	NULL
analysis	NULL
of	NULL
B7.1	NULL
surface	NULL
expression	NULL
on	NULL
M1	NULL
cells	NULL
either	NULL
stimulated	NULL
or	NULL
unstimulated	NULL
by	NULL
10	NULL
ng/ml	NULL
LPS	NULL
for	NULL
48	NULL
h	NULL
and	NULL
stained	NULL
with	NULL
Ab	NULL
to	NULL
mB7.1	NULL
(	NULL
1G10	NULL
)	NULL
or	NULL
control	NULL
Ab	NULL
are	NULL
shown	NULL
at	NULL
left	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Comparison	NULL
of	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
native	NULL
B7.1	NULL
promoter	NULL
and	NULL
the	NULL
heterologous	NULL
tk	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
enhancer	NULL
in	NULL
M12	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
over	NULL
that	NULL
of	NULL
the	NULL
respective	NULL
cloning	NULL
vectors	NULL
.	NULL

A	NULL
Lane	NULL
1	NULL
2	NULL
3	NULL
B	NULL
Plasmid	NULL
pSyncatl	NULL
!	NULL

B7.1	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
B7	NULL
.	NULL

Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
Mut	NULL
i	NULL
w	NULL
o	NULL
S	NULL
o	NULL
ue	NULL
w	NULL
ow	NULL
G+	NULL
Relative	NULL
CAT	NULL
Activity	NULL
TK	NULL
CJ	NULL
Hela	NULL
I	NULL
Raji	NULL
183	NULL
bp	NULL
188	NULL
bp	NULL
|	NULL
L_____________	NULL
TK	NULL
Tk	NULL
i	NULL
Cd	NULL
59	NULL
bp	NULL
142	NULL
bp	NULL
63	NULL
bp	NULL
e	NULL
TK	NULL
97	NULL
bp	NULL
L________	NULL
-3128	NULL
~3108	NULL
-3088	NULL
0	NULL
4	NULL
8	NULL
12	NULL
-3068	NULL
~3048	NULL
-3028	NULL
-3009	NULL
CCTTATAGACATGCCCAGATGAAGTCATATCTAAAAATGAACTTCTAAACCTCACGGGAGGGTCATCTTAGAACATGAAAAACTCCCCTGAAAATTTTTGTCAGTGCAACAGGTTTTGTT	NULL
«	NULL
TA.GACCL	NULL
G.	NULL
...	NULL
..	NULL
l..	NULL
eek	NULL
k	NULL
rae	NULL
re	NULL
erea	NULL
bae	NULL
re	NULL
nea	NULL
k	NULL
eee	NULL
ne	NULL
ra	NULL
ea	NULL
a	NULL
e	NULL
ere	NULL
pee	NULL
aa	NULL
eerie	NULL
a	NULL
~3008	NULL
-2988	NULL
-2968	NULL
-2946	NULL
TACTTGGCAACAGTGAGCCCACTCTGGCAAAGGGETTTTCCCAGCAGTCAGGCTAGCACCCTG	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
..	NULL
CTATGACC	NULL
.	NULL

G.	NULL
...	NULL
...	NULL
..	NULL
ee	NULL
.	NULL

l+	NULL
y	NULL
kes	NULL
ee	NULL
eek	NULL
ena	NULL
ee	NULL
eee	NULL
.	NULL

...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL
}	NULL

}	NULL
.	NULL

...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

TACTG.CCAG	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
..	NULL
CTA	NULL
.	NULL

GA.	NULL
CAGTG	NULL
.	NULL

soe	NULL
nv	NULL
ee	NULL
nkk	NULL
ea	NULL
eee	NULL
ees	NULL
aaa	NULL
es	NULL
...	NULL
..	NULL
«	NULL
<	NULL
+	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
CT.TGA	NULL
.	NULL

C	NULL
Gull	NULL
.	NULL

lly	NULL
ll	NULL
.	NULL

...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

CTA	NULL
.	NULL

GACCAG	NULL
otides	NULL
at	NULL
both	NULL
the	NULL
5	NULL
``	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
and	NULL
3	NULL
'	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
ends	NULL
of	NULL
the	NULL
enhancer	NULL
were	NULL
important	NULL
.	NULL

Furthermore	NULL
,	NULL
sequences	NULL
internal	NULL
to	NULL
these	NULL
were	NULL
also	NULL
involved	NULL
in	NULL
enhancer	NULL
activity	NULL
{	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
with	NULL
6	NULL
and	NULL
lanes	NULL
3	NULL
with	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
multiple	NULL
cis	NULL
elements	NULL
appeared	NULL
to	NULL
be	NULL
present	NULL
within	NULL
the	NULL
183-bp	NULL
fragment	NULL
.	NULL

To	NULL
precisely	NULL
delineate	NULL
the	NULL
sequences	NULL
within	NULL
the	NULL
183-bp	NULL
region	NULL
responsible	NULL
for	NULL
enhancer	NULL
function	NULL
,	NULL
linker-scanning	NULL
mutagenesis	NULL
was	NULL
performed	NULL
.	NULL

Each	NULL
linker-scanning	NULL
mutation	NULL
was	NULL
10	NULL
bp	NULL
in	NULL
length	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
mut	NULL
18	NULL
784	NULL
Regulation	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
which	NULL
was	NULL
13	NULL
bp	NULL
in	NULL
length	NULL
.	NULL

Several	NULL
bases	NULL
in	NULL
the	NULL
10-bp	NULL
stretch	NULL
were	NULL
mutated	NULL
to	NULL
one	NULL
of	NULL
the	NULL
three	NULL
remaining	NULL
nucleotides	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
with	NULL
each	NULL
resulting	NULL
sequence	NULL
checked	NULL
to	NULL
ascertain	NULL
that	NULL
no	NULL
known	NULL
promoter	NULL
motif	NULL
had	NULL
been	NULL
inadvertently	NULL
created	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutation	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
results	NULL
of	NULL
three	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
C.	NULL
Two	NULL
of	NULL
the	NULL
18	NULL
mutations	NULL
(	NULL
mut	NULL
2	NULL
and	NULL
16	NULL
)	NULL
led	NULL
to	NULL
particularly	NULL
striking	NULL
decreases	NULL
in	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
en-	NULL
20	NULL
-a	NULL
&	NULL
n	NULL
1	NULL
Relative	NULL
CAT	NULL
Activity	NULL
2	NULL
Region	NULL
5-Region	NULL
Region	NULL
o=	NULL
|	NULL
-	NULL
o	NULL
m	NULL
y	NULL
io	NULL
©	NULL
m	NULL
co	NULL
®	NULL
0m	NULL
nc	NULL
in	NULL
o	NULL
m	NULL
co	NULL
Region	NULL
§	NULL
PB	NULL
BB	NULL
GG	NULL
BGB	NULL
GG	NULL
Lule	NULL
ce	NULL
6	NULL
g	NULL
3	NULL
5	NULL
€	NULL
=	NULL
ss	NULL
ss	NULL
a	NULL
ui	NULL
ft	NULL
Region	NULL
CAMP-RE	NULL
T	NULL
GACGTCA	NULL
|	NULL
2	NULL
&	NULL
3	NULL
ATGCCCAGAT	NULL
GAAGTCATAT	NULL
4	NULL
9	NULL
aacrccccre	NULL
12	NULL
AGCTUTTGTT	NULL
NF-KB	NULL
ccooreryyH	NULL
cC	NULL
A	NULL
16	NULL
AGCcorrrTc	NULL
C	NULL
Figure	NULL
6.	NULL
.	NULL

Mutagenic	NULL
analysis	NULL
of	NULL
the	NULL
183-bp	NULL
B7.1	NULL
enhancer	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Regions	NULL
of	NULL
the	NULL
enhancer	NULL
were	NULL
analyzed	NULL
by	NULL
deletion	NULL
mutations	NULL
as	NULL
shown	NULL
in	NULL
one	NULL
initial	NULL
experiment	NULL
.	NULL

The	NULL
regions	NULL
corresponding	NULL
to	NULL
linker-scanning	NULL
mutations	NULL
2	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
16	NULL
are	NULL
marked	NULL
by	NULL
numbers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
sequence	NULL
of	NULL
the	NULL
hB7.1	NULL
enhancer	NULL
and	NULL
mutations	NULL
indicated	NULL
by	NULL
nucleotide	NULL
changes	NULL
.	NULL

The	NULL
NF-KB	NULL
binding	NULL
site	NULL
is	NULL
underlined	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
enhancer	NULL
activities	NULL
of	NULL
linker-scanning	NULL
mutants	NULL
in	NULL
transfected	NULL
Raji	NULL
cells	NULL
.	NULL

15	NULL
g	NULL
of	NULL
plasmid	NULL
DNA	NULL
was	NULL
used	NULL
for	NULL
each	NULL
transfection	NULL
.	NULL

The	NULL
relative	NULL
CAT	NULL
activity	NULL
of	NULL
mut	NULL
2	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
16	NULL
is	NULL
calculated	NULL
based	NULL
on	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Nucleotide	NULL
sequences	NULL
of	NULL
these	NULL
regions	NULL
as	NULL
well	NULL
as	NULL
that	NULL
of	NULL
region	NULL
3.	NULL
hancer	NULL
,	NULL
whereas	NULL
three	NULL
additional	NULL
mutations	NULL
(	NULL
mut	NULL
4	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
also	NULL
reproducibly	NULL
decreased	NULL
enhancer	NULL
activity	NULL
in	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
these	NULL
mutations	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
deletion	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
.	NULL

Several	NULL
additional	NULL
mutations	NULL
also	NULL
modestly	NULL
decreased	NULL
activity	NULL
(	NULL
mut	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

Inspection	NULL
of	NULL
the	NULL
mut	NULL
2	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
16	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
D	NULL
)	NULL
reveals	NULL
that	NULL
site	NULL
16	NULL
is	NULL
a	NULL
consensus	NULL
NF-KB	NULL
element	NULL
that	NULL
is	NULL
identical	NULL
both	NULL
in	NULL
its	NULL
core	NULL
nucleotides	NULL
and	NULL
in	NULL
the	NULL
flanking	NULL
nucleotides	NULL
to	NULL
the	NULL
NF-KB	NULL
site	NULL
in	NULL
the	NULL
Igxk	NULL
enhancer	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
element	NULL
resulted	NULL
in	NULL
>	NULL
70	NULL
%	NULL
abolition	NULL
of	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
remaining	NULL
four	NULL
sequences	NULL
do	NULL
not	NULL
bear	NULL
homology	NULL
to	NULL
known	NULL
promoter	NULL
motifs	NULL
as	NULL
checked	NULL
against	NULL
sequences	NULL
in	NULL
the	NULL
database	NULL
.	NULL

A	NULL
sequence	NULL
with	NULL
a	NULL
7/8	NULL
nucleotide	NULL
match	NULL
to	NULL
a	NULL
cAMP	NULL
response	NULL
element	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
enhancer	NULL
,	NULL
but	NULL
mutation	NULL
of	NULL
this	NULL
element	NULL
(	NULL
mut	NULL
3	NULL
)	NULL
has	NULL
minimal	NULL
effect	NULL
on	NULL
enhancer	NULL
activity	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
NF-KB	NULL
Family	NULL
Bind	NULL
to	NULL
the	NULL
B7.1	NULL
NF-KB	NULL
Site	NULL
.	NULL

-	NULL
Using	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
consensus	NULL
NF-KB	NULL
element	NULL
mutated	NULL
in	NULL
site	NULL
16	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
B7.1-positive	NULL
Raji	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
leff	NULL
)	NULL
.	NULL

A	NULL
DNA-protein	NULL
complex	NULL
could	NULL
be	NULL
observed	NULL
with	NULL
extracts	NULL
from	NULL
Raji	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
that	NULL
migrates	NULL
similarly	NULL
to	NULL
a	NULL
complex	NULL
observed	NULL
with	NULL
the	NULL
Igx	NULL
NF-KB	NULL
site	NULL
(	NULL
Fig.7	NULL
,	NULL
righ	NULL
?	NULL
)	NULL

.	NULL

That	NULL
this	NULL
complex	NULL
was	NULL
specific	NULL
was	NULL
shown	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
10-100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
NF-KB	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
unrelated	NULL
IL-4	NULL
promoter	NULL
,	NULL
to	NULL
prevent	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

The	NULL
multimember	NULL
NF-KB	NULL
family	NULL
includes	NULL
homologous	NULL
proteins	NULL
termed	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
,	NULL
.	NULL

Various	NULL
combinations	NULL
of	NULL
homo-	NULL
and	NULL
heterodimers	NULL
of	NULL
these	NULL
family	NULL
members	NULL
may	NULL
activate	NULL
or	NULL
repress	NULL
785	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
gene	NULL
transcription	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
family	NULL
members	NULL
present	NULL
in	NULL
Raji	NULL
cells	NULL
bound	NULL
to	NULL
this	NULL
site	NULL
,	NULL
supershift	NULL
EMSA	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
antisera	NULL
to	NULL
the	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
proteins	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
B	NULL
demonstrates	NULL
that	NULL
two	NULL
complexes	NULL
can	NULL
be	NULL
observed	NULL
{	NULL
arrows	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
lower	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
,	NULL
1	NULL
)	NULL
is	NULL
supershifted	NULL
by	NULL
Abs	NULL
to	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
,	NULL
suggesting	NULL
it	NULL
is	NULL
a	NULL
homo-	NULL
or	NULL
heterodimer	NULL
of	NULL
these	NULL
proteins	NULL
whereas	NULL
the	NULL
slower	NULL
migrating	NULL
upper	NULL
complex	NULL
(	NULL
Il	NULL
)	NULL
is	NULL
supershifted	NULL
by	NULL
the	NULL
Abs	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
suggesting	NULL
it	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
proteins	NULL
.	NULL

Such	NULL
homo-and	NULL
heterodimers	NULL
of	NULL
various	NULL
NF-KB	NULL
family	NULL
members	NULL
have	NULL
been	NULL
previously	NULL
observed	NULL
to	NULL
bind	NULL
NF-KB	NULL
target	NULL
sequences	NULL
in	NULL
many	NULL
promoters	NULL
(	NULL
47	NULL
,	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

The	NULL
p52	NULL
protein	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
B7.1	NULL
NF-KB	NULL
site	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
failure	NULL
of	NULL
the	NULL
anti-p52	NULL
Ab	NULL
to	NULL
affect	NULL
complex	NULL
formation	NULL
.	NULL

Cotransfection	NULL
of	NULL
M12	NULL
B	NULL
cells	NULL
with	NULL
the	NULL
183-bp	NULL
enhancer	NULL
and	NULL
NF-KB	NULL
subunits	NULL
p50	NULL
or	NULL
p65	NULL
expression	NULL
constructs	NULL
demonstrated	NULL
that	NULL
p65	NULL
transactivates	NULL
the	NULL
enhancer	NULL
,	NULL
whereas	NULL
p50	NULL
does	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
C	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
p50	NULL
decreases	NULL
transactivation	NULL
by	NULL
p65	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
known	NULL
role	NULL
of	NULL
p65	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
and	NULL
p50	NULL
as	NULL
a	NULL
repressor	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
description	NULL
to	NULL
our	NULL
knowledge	NULL
of	NULL
regulatory	NULL
elements	NULL
that	NULL
control	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
B7.1	NULL
costimulatory	NULL
molecule	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
tissue-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
~3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
human	NULL
B7.1	NULL
gene	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
cell	NULL
type-specific	NULL
enhancer	NULL
region	NULL
.	NULL

This	NULL
183-bp	NULL
region	NULL
was	NULL
both	NULL
cell	NULL
type	NULL
specific	NULL
and	NULL
responsive	NULL
to	NULL
two	NULL
distinct	NULL
stimuli	NULL
(	NULL
LPS	NULL
and	NULL
db-cAMP	NULL
)	NULL
known	NULL
to	NULL
regulate	NULL
B7.1	NULL
expression	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
cis	NULL
elements	NULL
within	NULL
this	NULL
region	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
a	NULL
NF-KB	NULL
consensus	NULL
sequence	NULL
.	NULL

This	NULL
element	NULL
binds	NULL
Probe	NULL
:	NULL
B7.1	NULL
Igx	NULL
Competitor	NULL
:	NULL
_	NULL
-	NULL
87.1	NULL
Igx	NULL
-	NULL
IL-4	NULL
mut	NULL
-	NULL
-	NULL
87.4	NULL
igx	NULL
_	NULL
IL-4	NULL
mut	NULL
I	NULL
x	NULL
x1	NULL
-l	NULL
x	NULL
x	NULL
l	NULL
4	NULL
g	NULL
4	NULL
g	NULL
4	NULL
f	NULL
5	NULL
s	NULL
5	NULL
s	NULL
$	NULL
§	NULL
§	NULL
§	NULL
§	NULL
§	NULL
&	NULL
&	NULL
§	NULL
§	NULL
&	NULL
§	NULL
5	NULL
@	NULL
Extract	NULL
:	NULL
_	NULL
4+	NULL
O4	NULL
4	NULL
b	NULL
F	NULL
b	NULL
4	NULL
o=	NULL
to	NULL
+	NULL
k	NULL
k	NULL
k	NULL
f	NULL
f	NULL
_	NULL
4	NULL
[	NULL
|	NULL
NF-xB-	NULL
»	NULL
10	NULL
2	NULL
8	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
40	NULL
f1	NULL
12	NULL
13	NULL
44	NULL
15	NULL
B	NULL
Probe	NULL
:	NULL
B7.1	NULL
o	NULL
33	NULL
©	NULL
o	NULL
Antiserum	NULL
:	NULL
E3	NULL
g	NULL
5:1	NULL
a	NULL
‘	NULL
21	NULL
d	NULL
,	NULL
E	NULL
E	NULL
’	NULL
Extract	NULL
:	NULL
_+	NULL
+	NULL
h	NULL
4	NULL
O+	NULL
+	NULL
+	NULL
_-NF-xB	NULL
-	NULL
»	NULL
'	NULL
I	NULL
U	NULL
--	NULL
II	NULL
p50	NULL
,	NULL
pS	NULL
Uth	NULL
b	NULL
W	NULL
t	NULL
=	NULL
|=	NULL
550-25	NULL
.	NULL

RelB	NULL
U	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
several	NULL
members	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
in	NULL
B7.1-positive	NULL
cells	NULL
and	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
the	NULL
p65	NULL
subunit	NULL
.	NULL

The	NULL
NF-KB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
cell	NULL
development	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
the	NULL
response	NULL
to	NULL
multiple	NULL
stimuli	NULL
.	NULL

The	NULL
five	NULL
members	NULL
of	NULL
this	NULL
fam-ily-p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
ReIB-all	NULL
contain	NULL
a	NULL
Rel-homology	NULL
domain	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

NF-KB	NULL
members	NULL
are	NULL
present	NULL
ubiquitously	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
many	NULL
different	NULL
cell	NULL
types	NULL
where	NULL
they	NULL
form	NULL
a	NULL
stable	NULL
complex	NULL
with	NULL
the	NULL
IKBa	NULL
and	NULL
IKBB	NULL
inhibitor	NULL
proteins	NULL
(	NULL
59	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Activation	NULL
by	NULL
mitogenic	NULL
factors	NULL
leads	NULL
to	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IKB	NULL
and	NULL
subsequent	NULL
translocation	NULL
of	NULL
NF-KB	NULL
proteins	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
61-64	NULL
)	NULL
.	NULL

Various	NULL
homo-	NULL
and	NULL
heterodimers	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
members	NULL
are	NULL
potent	NULL
transactivators	NULL
or	NULL
repressors	NULL
for	NULL
many	NULL
developmentally	NULL
regulated	NULL
genes	NULL
.	NULL

B7.1	NULL
expression	NULL
is	NULL
also	NULL
developmentally	NULL
regulated	NULL
and	NULL
responsive	NULL
to	NULL
stimull	NULL
known	NULL
to	NULL
increase	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
.	NULL

These	NULL
stimuli	NULL
include	NULL
LPS	NULL
(	NULL
65	NULL
)	NULL
,	NULL
cross-linking	NULL
of	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
by	NULL
soluble	NULL
CD40	NULL
ligand	NULL
(	NULL
66	NULL
,	NULL
67	NULL
)	NULL
,	NULL
or	NULL
ligation	NULL
of	NULL
B	NULL
cell	NULL
5	NULL
H	NULL
viz	NULL
I	NULL
4~	NULL
€	NULL
2	NULL
€	NULL
3	NULL
<	NULL
O	NULL
o	NULL
2	NULL
o	NULL
*	NULL
o	NULL
CC	NULL
1	NULL
-o-	NULL
_	NULL
p50	NULL
p6S	NULL
-	NULL
p50	NULL
+	NULL
p65	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
EMSA	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
in	NULL
the	NULL
hB7.1	NULL
enhancer	NULL
.	NULL

(	NULL
4	NULL
)	NULL
EMSA	NULL
complexes	NULL
are	NULL
shown	NULL
using	NULL
Raji	NULL
nuclear	NULL
extract	NULL
and	NULL
P-labeled	NULL
probes	NULL
of	NULL
the	NULL
hB7.1	NULL
and	NULL
Ig	NULL
enhancer	NULL
NF-KB	NULL
sequences	NULL
.	NULL

The	NULL
complexes	NULL
are	NULL
competed	NULL
by	NULL
excess	NULL
amounts	NULL
of	NULL
unlabeled	NULL
competitors	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Inhibition	NULL
of	NULL
NF-KB	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
hB7.1	NULL
enhancer	NULL
by	NULL
antisera	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
member	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
(	NULL
Reh	NULL
,	NULL
and	NULL
Rel-B	NULL
.	NULL

The	NULL
fast-migrating	NULL
NF-KB	NULL
complex	NULL
I	NULL
was	NULL
blocked	NULL
by	NULL
mAb	NULL
to	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Rel-B	NULL
,	NULL
and	NULL
the	NULL
slow-migrating	NULL
complex	NULL
II	NULL
was	NULL
blocked	NULL
by	NULL
mAb	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cotransfection	NULL
of	NULL
M12	NULL
cells	NULL
with	NULL
the	NULL
183-bp	NULL
Stuil-Apal	NULL
enhancer	NULL
construct	NULL
(	NULL
1	NULL
mg	NULL
)	NULL
and	NULL
NF-KB	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
5	NULL
jug	NULL
)	NULL
constructs	NULL
demonstrates	NULL
transactivation	NULL
by	NULL
p65	NULL
and	NULL
repression	NULL
by	NULL
p50	NULL
.	NULL

surface	NULL
Ig	NULL
(	NULL
68	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
NF-KB	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Mature	NULL
activated	NULL
B	NULL
cells	NULL
which	NULL
contain	NULL
constitutive	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
are	NULL
the	NULL
major	NULL
site	NULL
of	NULL
expression	NULL
of	NULL
B7.1	NULL
(	NULL
56	NULL
,	NULL
70	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Thymic	NULL
dendritic	NULL
cells	NULL
,	NULL
the	NULL
other	NULL
cell	NULL
type	NULL
that	NULL
constitutively	NULL
expresses	NULL
B7.1	NULL
,	NULL
are	NULL
critically	NULL
dependent	NULL
of	NULL
Rel-B	NULL
activity	NULL
since	NULL
Rel	NULL
B-deficient	NULL
mice	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
lack	NULL
mature	NULL
dendritic	NULL
cells	NULL
(	NULL
72	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
B7.1	NULL
expression	NULL
appears	NULL
to	NULL
parallel	NULL
NF-KB	NULL
activity	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
convergence	NULL
of	NULL
signal	NULL
transduction	NULL
for	NULL
B7.1-inducing	NULL
stimuli	NULL
on	NULL
this	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
clearly	NULL
indicate	NULL
that	NULL
other	NULL
cis	NULL
elements	NULL
also	NULL
control	NULL
B7.1	NULL
expression	NULL
.	NULL

Several	NULL
additional	NULL
cis	NULL
elements	NULL
with	NULL
no	NULL
obvious	NULL
homology	NULL
to	NULL
known	NULL
promoter	NULL
motifs	NULL
were	NULL
critical	NULL
for	NULL
functional	NULL
enhancer	NULL
activity	NULL
.	NULL

Now	NULL
that	NULL
a	NULL
B7.1-specific	NULL
enhancer	NULL
that	NULL
functions	NULL
in	NULL
concert	NULL
with	NULL
a	NULL
mimimal	NULL
promoter	NULL
has	NULL
been	NULL
delineated	NULL
,	NULL
identification	NULL
of	NULL
the	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
these	NULL
additional	NULL
elements	NULL
will	NULL
be	NULL
key	NULL
in	NULL
further	NULL
understanding	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
important	NULL
costimulatory	NULL
molecule	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

A.	NULL
Reimold	NULL
and	NULL
D.	NULL
Singer	NULL
for	NULL
careful	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
Dr.	NULL
R.	NULL
Sen	NULL
for	NULL
p50	NULL
and	NULL
p65	NULL
constructs	NULL
,	NULL
and	NULL
Ms.	NULL
Carol	NULL
Freedman	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
Al-21569	NULL
(	NULL
LH	NULL
.	NULL

Glimcher	NULL
)	NULL
,	NULL
CA-34183	NULL
and	NULL
CA-40416	NULL
(	NULL
G.	NULL
]	NULL
.	NULL

Freeman	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Insitutes	NULL
of	NULL
Health	NULL
,	NULL
a	NULL
fellowship	NULL
award	NULL
from	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
(	NULL
J.-L.	NULL
Zhao	NULL
)	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Council	NULL
on	NULL
Tobacco	NULL
Research	NULL
(	NULL
LH	NULL
.	NULL

Glimcher	NULL
)	NULL
.	NULL

786	NULL
Regulation	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Laurie	NULL
H.	NULL
Glimcher	NULL
,	NULL
Department	NULL
of	NULL
Cancer	NULL
Biology	NULL
,	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
667	NULL
Huntington	NULL
Avenue	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
7	NULL
August	NULL
1995	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
26	NULL
October	NULL
1995	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Janeway	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
and	NULL
K.	NULL
Bottomly	NULL
.	NULL

1994	NULL
.	NULL

Signals	NULL
and	NULL
signs	NULL
for	NULL
lymphocyte	NULL
responses	NULL
.	NULL

Cell	NULL
.	NULL

76:275-285	NULL
.	NULL

2	NULL
.	NULL

June	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
M.C	NULL
.	NULL

Fletcher	NULL
,	NULL
J.A	NULL
.	NULL

Ledbetter	NULL
,	NULL
G.L	NULL
.	NULL

Schieven	NULL
,	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

J.N	NULL
.	NULL

Siegel	NULL
,	NULL
A.F	NULL
.	NULL

Phillips	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1990	NULL
.	NULL

Inhibition	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
prevents	NULL
T-cell	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sai	NULL
.	NULL

USA	NULL
.	NULL

87	NULL
:	NULL
7722-7726.	NULL
.	NULL

Mustelin	NULL
,	NULL
G.	NULL
,	NULL
K.M	NULL
.	NULL

Coggeshall	NULL
,	NULL
N.	NULL
Isakov	NULL
,	NULL
and	NULL
A.	NULL
Altman	NULL
.	NULL

1990	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
activation	NULL
of	NULL
phos-pholipase	NULL
C	NULL
requires	NULL
phosphorylation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

247:1584-1587.	NULL
.	NULL

Damle	NULL
,	NULL
N.K	NULL
.	NULL

,	NULL
K.	NULL
Klussman	NULL
,	NULL
P.S	NULL
.	NULL

Linsley	NULL
,	NULL
and	NULL
A.	NULL
Aruffo	NULL
.	NULL

1992	NULL
.	NULL

Defferential	NULL
costimulatory	NULL
effects	NULL
of	NULL
adhesion	NULL
molecules	NULL
B7	NULL
,	NULL
ICAM-1	NULL
,	NULL
LFA-3	NULL
,	NULL
and	NULL
VCAM-1	NULL
on	NULL
resting	NULL
and	NULL
an-tigen-primed	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1985-1992.	NULL
.	NULL

Gimmi	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
G.J	NULL
.	NULL

Freeman	NULL
,	NULL
J.G	NULL
.	NULL

Grien	NULL
,	NULL
G.	NULL
Gray	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Nadler	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
T-cell	NULL
clonal	NULL
anergy	NULL
is	NULL
induced	NULL
by	NULL
antigen	NULL
presentation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
B7	NULL
costimulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:6586-6590.	NULL
.	NULL

Chen	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
N.	NULL
Nabavi	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vitro	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
by	NULL
blocking	NULL
B7	NULL
and	NULL
early	NULL
T	NULL
cell	NULL
costimulatory	NULL
molecule	NULL
ETC-1/B7-2	NULL
.	NULL

Immunity	NULL
.	NULL

1:147-154.	NULL
.	NULL

Green	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
PJ	NULL
.	NULL

Noel	NULL
,	NULL
A.J	NULL
.	NULL

Sperling	NULL
,	NULL
TL	NULL
.	NULL

Walunas	NULL
,	NULL
G.S	NULL
.	NULL

Gray	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
and	NULL
C.B	NULL
.	NULL

Thompson	NULL
.	NULL

1994	NULL
.	NULL

Absence	NULL
of	NULL
B7-dependent	NULL
responses	NULL
in	NULL
CD28-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

1:501-508.	NULL
.	NULL

Freeman	NULL
,	NULL
GJ	NULL
.	NULL

,	NULL
G.S	NULL
.	NULL

Gray	NULL
,	NULL
C.D	NULL
.	NULL

Gimmi	NULL
,	NULL
D.B	NULL
.	NULL

Lombard	NULL
,	NULL
LJ	NULL
.	NULL

Zhou	NULL
,	NULL
M.	NULL
White	NULL
,	NULL
J.D	NULL
.	NULL

Fingeroth	NULL
,	NULL
J.G	NULL
.	NULL

Griggen	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Nadler	NULL
.	NULL

1991	NULL
.	NULL

Structure	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
T	NULL
cell	NULL
costimulatory	NULL
activity	NULL
of	NULL
the	NULL
murine	NULL
homologue	NULL
of	NULL
the	NULL
human	NULL
B	NULL
lymphocyte	NULL
activation	NULL
antigen	NULL
B7	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:625-631.	NULL
.	NULL

Freeman	NULL
,	NULL
GJ	NULL
.	NULL

,	NULL
J.G	NULL
.	NULL

Gribben	NULL
,	NULL
V.A	NULL
.	NULL

Boussiotis	NULL
,	NULL
J.JW.Ng	NULL
,	NULL
V.	NULL
J.	NULL
Restivo	NULL
,	NULL
L.A.	NULL
Lombard	NULL
,	NULL
G.S	NULL
.	NULL

Gray	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Nadler	NULL
.	NULL

1993	NULL
.	NULL

Cloning	NULL
of	NULL
B7-2	NULL
:	NULL
a	NULL
CTLA-4	NULL
counter-receptor	NULL
that	NULL
costimu-lates	NULL
human	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262	NULL
:	NULL
909-911	NULL
.	NULL

Azuma	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Ito	NULL
,	NULL
H.	NULL
Yagita	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
J.H	NULL
.	NULL

Phillips	NULL
,	NULL
LL	NULL
.	NULL

Lanier	NULL
,	NULL
and	NULL
C.	NULL
Somoza	NULL
.	NULL

1993	NULL
.	NULL

B70	NULL
antigen	NULL
is	NULL
a	NULL
second	NULL
ligand	NULL
for	NULL
CTLA-4	NULL
and	NULL
CD28	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

366:76-79	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Vanbervliet	NULL
,	NULL
C.	NULL
Massacrier	NULL
,	NULL
M.	NULL
Azuma	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
L.L	NULL
.	NULL

Lanier	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1994	NULL
.	NULL

B70/B7-2	NULL
is	NULL
identical	NULL
to	NULL
CD86	NULL
and	NULL
is	NULL
the	NULL
major	NULL
functional	NULL
ligand	NULL
for	NULL
CD28	NULL
expressed	NULL
on	NULL
human	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
:	NULL
1841-1847	NULL
.	NULL

Linsley	NULL
,	NULL
P.S	NULL
.	NULL

,	NULL
J.L	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
Brady	NULL
,	NULL
J.	NULL
Bajorath	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
R.	NULL
Peach	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
B7-1	NULL
(	NULL
CD80	NULL
)	NULL
and	NULL
B7-2	NULL
(	NULL
CD86	NULL
)	NULL
bind	NULL
with	NULL
similar	NULL
avidities	NULL
but	NULL
distinct	NULL
kinetics	NULL
to	NULL
CD28	NULL
and	NULL
CTLA-4	NULL
receptors	NULL
.	NULL

Immunity	NULL
.	NULL

1:793-801	NULL
.	NULL

Lanier	NULL
,	NULL
LL	NULL
.	NULL

,	NULL
S.	NULL
O'Fallon	NULL
,	NULL
C.	NULL
Somoza	NULL
,	NULL
J.	NULL
H.	NULL
Phillips	NULL
,	NULL
P.S	NULL
.	NULL

Linsley	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
D.	NULL
Ito	NULL
,	NULL
and	NULL
M.	NULL
Azuma	NULL
.	NULL

1995	NULL
.	NULL

CD80	NULL
(	NULL
B7	NULL
)	NULL
and	NULL
CD86	NULL
(	NULL
B70	NULL
)	NULL
provide	NULL
similar	NULL
costimulatory	NULL
signals	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
cytokine	NULL
production	NULL
,	NULL
and	NULL
generation	NULL
of	NULL
CTL	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:97-105	NULL
.	NULL

Tan	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Anasetti	NULL
,	NULL
J.A	NULL
.	NULL

Hansen	NULL
,	NULL
J.	NULL
Melrose	NULL
,	NULL
M.	NULL
Brunvand	NULL
,	NULL
787	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

J.	NULL
Bradshaw	NULL
,	NULL
J.A	NULL
.	NULL

Ledbetter	NULL
,	NULL
and	NULL
P.S	NULL
.	NULL

Linsley	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
alloantigen-specific	NULL
hyporesponsiveness	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
blocking	NULL
interaction	NULL
of	NULL
CD28	NULL
with	NULL
its	NULL
natural	NULL
ligand	NULL
B7/BB1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:165-173	NULL
.	NULL

Freeman	NULL
,	NULL
G.J	NULL
.	NULL

,	NULL
F.	NULL
Botriello	NULL
,	NULL
R.J.	NULL
Hodes	NULL
,	NULL
H.	NULL
Reiser	NULL
,	NULL
K.S	NULL
.	NULL

Hathcock	NULL
,	NULL
G.	NULL
Laszlo	NULL
,	NULL
AJ	NULL
.	NULL

McKnight	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
L.	NULL
Du	NULL
,	NULL
D.B	NULL
.	NULL

Lombard	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Uncovering	NULL
of	NULL
functional	NULL
alternative	NULL
CTLA-4	NULL
counter-receptor	NULL
in	NULL
B7-deficient	NULL
mice	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:907-909	NULL
.	NULL

Kuchroo	NULL
,	NULL
V.K	NULL
.	NULL

,	NULL
M.P	NULL
.	NULL

Das	NULL
,	NULL
J.A	NULL
.	NULL

Brown	NULL
,	NULL
A.M.	NULL
Ranger	NULL
,	NULL
S.S.	NULL
Zamvil	NULL
,	NULL
R.A.	NULL
Sobel	NULL
,	NULL
HL	NULL
.	NULL

Weiner	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1995	NULL
.	NULL

B7-1	NULL
and	NULL
B7-2	NULL
costimulatory	NULL
molecules	NULL
activate	NULL
differentially	NULL
the	NULL
Thi/Th2	NULL
developmental	NULL
pathways	NULL
:	NULL
application	NULL
to	NULL
autoimmune	NULL
disease	NULL
therapy	NULL
.	NULL

Cell	NULL
.	NULL

80:707-718	NULL
.	NULL

Lenschow	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Y.	NULL
Zeng	NULL
,	NULL
JR.	NULL
Thistlethwaite	NULL
,	NULL
A.	NULL
Montag	NULL
,	NULL
W.	NULL
Brady	NULL
,	NULL
M.G	NULL
.	NULL

Gibson	NULL
,	NULL
P.S	NULL
.	NULL

Linsley	NULL
,	NULL
and	NULL
J.A	NULL
.	NULL

Bluestone	NULL
.	NULL

1992	NULL
.	NULL

Long-term	NULL
survival	NULL
of	NULL
xenogeneic	NULL
pancreatic	NULL
islet	NULL
grafts	NULL
induced	NULL
by	NULL
CTLA4lg	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

257:789-792	NULL
.	NULL

Azuma	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.H	NULL
.	NULL

Phillips	NULL
,	NULL
H.	NULL
Spits	NULL
,	NULL
and	NULL
LL	NULL
.	NULL

Lanier	NULL
.	NULL

1993	NULL
.	NULL

Functional	NULL
expression	NULL
of	NULL
B7/BB1	NULL
on	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:845-850	NULL
.	NULL

Prabhu	NULL
Das	NULL
,	NULL
MR.	NULL
,	NULL
S.S.	NULL
Zamvil	NULL
,	NULL
F.	NULL
Borriello	NULL
,	NULL
HL	NULL
.	NULL

Weiner	NULL
,	NULL
AH	NULL
.	NULL

Sharpe	NULL
,	NULL
and	NULL
VK	NULL
.	NULL

Kuchroo	NULL
.	NULL

1995	NULL
.	NULL

Reciprocal	NULL
expression	NULL
of	NULL
co-stimulatory	NULL
molecules	NULL
,	NULL
B7-1	NULL
and	NULL
B7-2	NULL
,	NULL
on	NULL
murine	NULL
T	NULL
cells	NULL
following	NULL
activation	NULL
.	NULL

Fur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:207-211	NULL
.	NULL

Hathcock	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
G.	NULL
Laszlo	NULL
,	NULL
HB	NULL
.	NULL

Dickler	NULL
,	NULL
J.	NULL
Bradshaw	NULL
,	NULL
P.	NULL
Linsley	NULL
,	NULL
and	NULL
R.J.	NULL
Hodes	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
alternative	NULL
CTLA-4	NULL
ligand	NULL
costimulatory	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:905-907	NULL
.	NULL

Ding	NULL
,	NULL
L.	NULL
,	NULL
P.S	NULL
.	NULL

Linsley	NULL
,	NULL
L.	NULL
Y.Huang	NULL
,	NULL
R.N	NULL
.	NULL

Germain	NULL
,	NULL
and	NULL
EM	NULL
.	NULL

Shevach	NULL
.	NULL

1993	NULL
,	NULL
IL-10	NULL
inhibits	NULL
macrophage	NULL
costimulatory	NULL
activity	NULL
by	NULL
selectively	NULL
inhibiting	NULL
the	NULL
up-regulation	NULL
of	NULL
B7	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:1224-1234	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.A	NULL
.	NULL

,	NULL
G.J	NULL
.	NULL

Freeman	NULL
,	NULL
J.G	NULL
.	NULL

Gribben	NULL
,	NULL
J.	NULL
Daley	NULL
,	NULL
G.	NULL
Gray	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Nadler	NULL
.	NULL

1993	NULL
.	NULL

Activated	NULL
human	NULL
B	NULL
lymphocytes	NULL
express	NULL
three	NULL
CTLA-4	NULL
counterreceptors	NULL
that	NULL
costimu-late	NULL
T-cell	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:11059-11063	NULL
.	NULL

Hathcock	NULL
,	NULL
L.S	NULL
.	NULL

,	NULL
G.	NULL
Laszlo	NULL
,	NULL
C.	NULL
Pucillo	NULL
,	NULL
P.	NULL
Linsley	NULL
,	NULL
and	NULL
R.J.	NULL
Hodes	NULL
.	NULL

1994	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
B7-1	NULL
and	NULL
B7-2	NULL
costimulatory	NULL
ligands	NULL
:	NULL
expression	NULL
and	NULL
function	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
:	NULL
631-640	NULL
.	NULL

Stack	NULL
,	NULL
RM	NULL
.	NULL

,	NULL
DJ	NULL
.	NULL

Lenschow	NULL
,	NULL
G.S	NULL
.	NULL

Gray	NULL
,	NULL
J.A	NULL
.	NULL

Bluestone	NULL
,	NULL
and	NULL
FW	NULL
.	NULL

Fitch	NULL
.	NULL

1994	NULL
.	NULL

IL-4	NULL
treatment	NULL
of	NULL
small	NULL
splenic	NULL
B	NULL
cells	NULL
induces	NULL
costimulatory	NULL
molecules	NULL
B7-1	NULL
and	NULL
B7-2	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:5723-5733	NULL
.	NULL

Yellin	NULL
,	NULL
M.J.	NULL
,	NULL
J.	NULL
Sinning	NULL
,	NULL
LR	NULL
.	NULL

Covey	NULL
,	NULL
W.	NULL
Sherman	NULL
,	NULL
J.J.	NULL
Lee	NULL
,	NULL
N.E	NULL
.	NULL

Glickman	NULL
,	NULL
K.C	NULL
.	NULL

Sippel	NULL
,	NULL
J.	NULL
Rogers	NULL
,	NULL
A.M.	NULL
Cleary	NULL
,	NULL
M.	NULL
Parker	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

T	NULL
lymphocyte	NULL
T	NULL
cell-B	NULL
cell-activating	NULL
molecule/CD40-L	NULL
molecules	NULL
induce	NULL
normal	NULL
B	NULL
cells	NULL
or	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
B	NULL
cells	NULL
to	NULL
express	NULL
CD80	NULL
(	NULL
B7/	NULL
BB-1	NULL
)	NULL
and	NULL
enhance	NULL
their	NULL
costimulatory	NULL
activity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:666-674	NULL
.	NULL

Valle	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Garrone	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.Y	NULL
.	NULL

Bonnefoy	NULL
,	NULL
A.S.	NULL
Freedman	NULL
,	NULL
G.	NULL
Freeman	NULL
,	NULL
LM	NULL
.	NULL

Nadler	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1990	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

36	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42.	NULL
mAb	NULL
104	NULL
,	NULL
a	NULL
new	NULL
monoclonal	NULL
antibody	NULL
,	NULL
recognizes	NULL
the	NULL
B7	NULL
antigen	NULL
that	NULL
is	NULL
expressed	NULL
on	NULL
activated	NULL
B	NULL
cells	NULL
and	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
.	NULL

Immunology	NULL
.	NULL

69:531-535	NULL
.	NULL

Nabavi	NULL
,	NULL
N.	NULL
,	NULL
G.J	NULL
.	NULL

Freeman	NULL
,	NULL
A.	NULL
Gault	NULL
,	NULL
1D	NULL
)	NULL
.	NULL

Godfrey	NULL
,	NULL
LM	NULL
.	NULL

Nadler	NULL
,	NULL
and	NULL
L.H	NULL
.	NULL

Glimcher	NULL
.	NULL

1992	NULL
.	NULL

Signalling	NULL
through	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
antigen	NULL
presentation	NULL
and	NULL
induces	NULL
B7	NULL
expression	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

360:266-268	NULL
.	NULL

Watts	NULL
,	NULL
TH	NULL
.	NULL

,	NULL
N.	NULL
Alaverdi	NULL
,	NULL
W.F	NULL
.	NULL

Wade	NULL
,	NULL
and	NULL
P.S	NULL
.	NULL

Linsley	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
costimulatory	NULL
molecule	NULL
B7	NULL
in	NULL
M12	NULL
B	NULL
lymphomas	NULL
by	NULL
cAMP	NULL
or	NULL
MHC-restricted	NULL
T	NULL
cell	NULL
interaction	NULL
.	NULL

_J	NULL
.	NULL

Immunol	NULL
.	NULL

150:2192-2202	NULL
.	NULL

Freedman	NULL
,	NULL
A.S.	NULL
,	NULL
G.J	NULL
.	NULL

Freeman	NULL
,	NULL
K.	NULL
Rhynhart	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Nadler	NULL
.	NULL

1991	NULL
.	NULL

Selective	NULL
induction	NULL
of	NULL
B7/BB-1	NULL
on	NULL
interferon-y	NULL
stimulated	NULL
monocytes	NULL
:	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
amplification	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
through	NULL
the	NULL
CD28	NULL
pathway	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

137:429-437	NULL
.	NULL

Freeman	NULL
,	NULL
G.J	NULL
.	NULL

,	NULL
A.S.	NULL
Freedman	NULL
,	NULL
J.M	NULL
.	NULL

Segil	NULL
,	NULL
G.	NULL
Lee	NULL
,	NULL
J.F	NULL
.	NULL

Whit-man	NULL
,	NULL
and	NULL
L.M	NULL
.	NULL

Nadler	NULL
.	NULL

1989	NULL
.	NULL

B7	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
superfamily	NULL
with	NULL
unique	NULL
expression	NULL
on	NULL
activated	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:2714-2722	NULL
.	NULL

Selvakumar	NULL
,	NULL
A.	NULL
,	NULL
B.K	NULL
.	NULL

Mohanraj	NULL
,	NULL
RL	NULL
.	NULL

Eddy	NULL
,	NULL
T.B	NULL
.	NULL

Shows	NULL
,	NULL
P.C	NULL
.	NULL

White	NULL
,	NULL
and	NULL
B.	NULL
Dupont	NULL
.	NULL

1992	NULL
.	NULL

Genomic	NULL
organization	NULL
and	NULL
chromosomal	NULL
location	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
encoding	NULL
the	NULL
B-lymphocyte	NULL
activation	NULL
antigen	NULL
B7	NULL
.	NULL

Immunogenetics	NULL
.	NULL

35:175-181	NULL
.	NULL

Selvakumar	NULL
,	NULL
L.	NULL
,	NULL
P.C	NULL
.	NULL

White	NULL
,	NULL
and	NULL
B.	NULL
Dupont	NULL
.	NULL

1993	NULL
.	NULL

Genomic	NULL
organization	NULL
of	NULL
the	NULL
mouse	NULL
B-lymphocyte	NULL
activation	NULL
antigen	NULL
B7	NULL
.	NULL

Immunogenetics	NULL
.	NULL

38:292-295	NULL
.	NULL

Borriello	NULL
,	NULL
F.	NULL
,	NULL
G.J	NULL
.	NULL

Freeman	NULL
,	NULL
S.	NULL
Edelhoff	NULL
,	NULL
C.M	NULL
.	NULL

Disteche	NULL
,	NULL
L.M	NULL
.	NULL

Nadler	NULL
,	NULL
and	NULL
A.H.	NULL
Sharpe	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
murine	NULL
B7-1	NULL
genomic	NULL
locus	NULL
reveals	NULL
an	NULL
additional	NULL
exon	NULL
encoding	NULL
an	NULL
alternative	NULL
cytoplasmic	NULL
domain	NULL
and	NULL
a	NULL
chromosomal	NULL
location	NULL
of	NULL
chromosome	NULL
16	NULL
,	NULL
band	NULL
B5	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5038-5048	NULL
.	NULL

Saito	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Koyama	NULL
,	NULL
K.	NULL
Georgopoulos	NULL
,	NULL
H.	NULL
Clevers	NULL
,	NULL
W.G	NULL
.	NULL

Haser	NULL
,	NULL
T.	NULL
LeBien	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1987	NULL
.	NULL

Close	NULL
linkage	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
CD3	NULL
y-	NULL
and	NULL
8-chain	NULL
genes	NULL
suggests	NULL
that	NULL
their	NULL
transcription	NULL
is	NULL
controlled	NULL
by	NULL
common	NULL
regulatory	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

84:913-9134.	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Labora-tory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
,	NULL
and	NULL
AR	NULL
.	NULL

Coulson	NULL
.	NULL

1977	NULL
.	NULL

DNA	NULL
sequencing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
,	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

74:5463-5467.	NULL
.	NULL

Devereux	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Haeberli	NULL
,	NULL
and	NULL
O.	NULL
Smithies	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
compre-	NULL
hensive	NULL
set	NULL
of	NULL
sequence	NULL
analysis	NULL
programs	NULL
for	NULL
the	NULL
VAX	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:387-395	NULL
.	NULL

Ivashkiv	NULL
,	NULL
L.B	NULL
.	NULL

,	NULL
M.D	NULL
.	NULL

Fleming	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1992	NULL
.	NULL

Dominant	NULL
negative	NULL
mutants	NULL
of	NULL
transcription	NULL
factor	NULL
mXBP	NULL
(	NULL
CRE-BP1	NULL
,	NULL
ATF-2	NULL
)	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

4:360-368	NULL
.	NULL

Freedman	NULL
,	NULL
A.S.	NULL
,	NULL
G.	NULL
Freeman	NULL
,	NULL
J.C.	NULL
Horowitz	NULL
,	NULL
J.	NULL
Daley	NULL
,	NULL
and	NULL
L.M	NULL
.	NULL

Nadler	NULL
.	NULL

1987	NULL
.	NULL

B7	NULL
,	NULL
a	NULL
B-cell-restricted	NULL
antigen	NULL
that	NULL
identifies	NULL
preactivated	NULL
B	NULL
Cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:3260-3267	NULL
.	NULL

Liou	NULL
,	NULL
H.C.	NULL
,	NULL
B.S	NULL
.	NULL

Polla	NULL
,	NULL
D.	NULL
Aragnol	NULL
,	NULL
LD	NULL
.	NULL

Leserman	NULL
,	NULL
L.J	NULL
.	NULL

Grif-fith	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
tissue-specific	NULL
DNase	NULL
I-hyper-sensitive	NULL
site	NULL
in	NULL
a	NULL
class	NULL
II	NULL
A	NULL
alpha	NULL
gene	NULL
is	NULL
under	NULL
trans-regula-tory	NULL
control	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:2738-2742	NULL
.	NULL

Ponath	NULL
,	NULL
P.D	NULL
.	NULL

,	NULL
1D	NULL
.	NULL

Fass	NULL
,	NULL
H.C.	NULL
Liou	NULL
,	NULL
LH	NULL
.	NULL

Glimcher	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
regulatory	NULL
gene	NULL
,	NULL
hXBP-1	NULL
,	NULL
and	NULL
its	NULL
tar-get	NULL
,	NULL
HLA-DRA	NULL
,	NULL
utilize	NULL
both	NULL
common	NULL
and	NULL
distinct	NULL
regulatory	NULL
clements	NULL
and	NULL
protein	NULL
complexes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:17074-17082	NULL
.	NULL

Reimold	NULL
,	NULL
A.M.	NULL
,	NULL
C.J	NULL
.	NULL

Kara	NULL
,	NULL
JW	NULL
.	NULL

Rooney	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1993	NULL
.	NULL

Transforming	NULL
growth	NULL
factor	NULL
B1	NULL
repression	NULL
of	NULL
the	NULL
788	NULL
Regulation	NULL
of	NULL
the	NULL
B7.1	NULL
Gene	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

54	NULL
.	NULL

56	NULL
.	NULL

HLA-DRa	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
conserved	NULL
proximal	NULL
promoter	NULL
elements	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:4173-4182.	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Broser	NULL
,	NULL
and	NULL
W.N	NULL
.	NULL

Rom	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin	NULL
6	NULL
gene	NULL
by	NULL
Mycobacterium	NULL
tuberculosis	NULL
or	NULL
lipopolysaccharide	NULL
is	NULL
mediated	NULL
by	NULL
nuclear	NULL
factors	NULL
NF-IL6	NULL
and	NULL
NF-KB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:2225-2229	NULL
.	NULL

Mikaelian	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
general	NULL
and	NULL
fast	NULL
method	NULL
to	NULL
generate	NULL
multiple	NULL
site	NULL
directed	NULL
mutations	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:376	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.R	NULL
.	NULL

Hodge	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
L.H	NULL
.	NULL

Glimcher	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:625-633	NULL
.	NULL

Liou	NULL
,	NULL
H.C.	NULL
,	NULL
M.R	NULL
.	NULL

Boothby	NULL
,	NULL
P.W	NULL
.	NULL

Finn	NULL
,	NULL
R.	NULL
Davidon	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
LN	NULL
.	NULL

Zeleznik	NULL
,	NULL
J.P.	NULL
Ting	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
new	NULL
member	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
class	NULL
of	NULL
proteins	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
HLA	NULL
DRa	NULL
promoter	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

247:1581-1584	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
k	NULL
immuno-globulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
B	NULL
by	NULL
a	NULL
posttransla-tional	NULL
mechanism	NULL
.	NULL

Cell	NULL
.	NULL

47:921-928	NULL
.	NULL

Banas	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
Blaschke	NULL
,	NULL
F.	NULL
Fittler	NULL
,	NULL
and	NULL
W.	NULL
Horz	NULL
.	NULL

1994	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
prostatic	NULL
acid	NULL
phosphatase	NULL
gene	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1217:188-194	NULL
.	NULL

Riccio	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
and	NULL
G.M	NULL
.	NULL

Rossolini	NULL
.	NULL

1993	NULL
.	NULL

Unusual	NULL
clustering	NULL
of	NULL
Alu	NULL
repeats	NULL
within	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
lysozyme	NULL
gene	NULL
.	NULL

DNA	NULL
Sequence	NULL
.	NULL

4:129-134	NULL
.	NULL

50	NULL
.	NULL

Jankevics	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
Makarenkova	NULL
,	NULL
A.	NULL
Tsimanis	NULL
,	NULL
and	NULL
E.	NULL
Grens	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1217:235-238.	NULL
.	NULL

Dombroski	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
A.F	NULL
.	NULL

Scott	NULL
,	NULL
and	NULL
H.J	NULL
.	NULL

Kazazian	NULL
.	NULL

1993	NULL
.	NULL

Two	NULL
additional	NULL
potential	NULL
retrotransposons	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
L1	NULL
subfamily	NULL
that	NULL
contains	NULL
an	NULL
active	NULL
retrotransposable	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sai	NULL
.	NULL

USA	NULL
.	NULL

90:6513-6517.	NULL
.	NULL

Dombroski	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
S.L	NULL
.	NULL

Mathias	NULL
,	NULL
E.	NULL
Nanthakumar	NULL
,	NULL
A.F	NULL
.	NULL

Scott	NULL
,	NULL
and	NULL
HJ	NULL
.	NULL

Kazazian	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
an	NULL
active	NULL
human	NULL
trans-posable	NULL
element	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

254:1805-1808.	NULL
.	NULL

Fong	NULL
,	NULL
T.C	NULL
.	NULL

,	NULL
and	NULL
T.J.	NULL
Kipps	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
human	NULL
CD80	NULL
(	NULL
B7-1	NULL
)	NULL
promoter	NULL
contains	NULL
an	NULL
NF	NULL
element	NULL
that	NULL
is	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activity	NULL
in	NULL
B7-expressing	NULL
cells	NULL
.	NULL

The	NULL
9th	NULL
International	NULL
Congress	NULL
of	NULL
Immunology	NULL
,	NULL
July	NULL
23-29	NULL
,	NULL
San	NULL
Fran-cisco	NULL
,	NULL
CA	NULL
.	NULL

4170:702	NULL
(	NULL
Abstr	NULL
.	NULL
)	NULL

Yellin	NULL
,	NULL
M.J.	NULL
,	NULL
K.	NULL
Sippel	NULL
,	NULL
G.	NULL
Inghirami	NULL
,	NULL
LR	NULL
.	NULL

Covey	NULL
,	NULL
J	NULL
J.	NULL
Lee	NULL
,	NULL
J.	NULL
Sinning	NULL
,	NULL
E.A	NULL
.	NULL

Clark	NULL
,	NULL
L.	NULL
Chess	NULL
,	NULL
and	NULL
S.	NULL
Lederman	NULL
.	NULL

1994	NULL
.	NULL

CD40	NULL
molecules	NULL
induce	NULL
down-modulation	NULL
and	NULL
endocytosis	NULL
of	NULL
T	NULL
cell	NULL
surface	NULL
T	NULL
Cell-B	NULL
cell	NULL
activating	NULL
molecule/C140-L	NULL
.	NULL

Potential	NULL
role	NULL
in	NULL
regulating	NULL
helper	NULL
effector	NULL
function	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152	NULL
:	NULL
598-608.	NULL
.	NULL

Lerubecher	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Kistler	NULL
,	NULL
and	NULL
T.	NULL
Wirth	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
distinct	NULL
mechanisms	NULL
contribute	NULL
to	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
RelB	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:4060-4069	NULL
.	NULL

Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
M.J.	NULL
Schmitt	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Verma	NULL
.	NULL

1994	NULL
.	NULL

Qualitative	NULL
changes	NULL
in	NULL
the	NULL
subunit	NULL
composition	NULL
of	NULL
kB-binding	NULL
complexes	NULL
during	NULL
murine	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:5056-5060.	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Arsura	NULL
,	NULL
M.	NULL
Wu	NULL
,	NULL
M.	NULL
Duyao	NULL
,	NULL
A.J	NULL
.	NULL

Buckler	NULL
,	NULL
and	NULL
G.E	NULL
.	NULL

Sonenshein	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
Rel-related	NULL
factors	NULL
in	NULL
control	NULL
of	NULL
c-myc	NULL
gene	NULL
transcription	NULL
in	NULL
receptor-mediated	NULL
apop-tosid	NULL
of	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
WEHI	NULL
231	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
;	NULL
1169-1177.	NULL
.	NULL

Baldwin	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
and	NULL
P.A	NULL
.	NULL

Sharp	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
transcription	NULL
fac-	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65.	NULL
tors	NULL
,	NULL
NF-KB	NULL
and	NULL
H2TF1	NULL
,	NULL
interact	NULL
with	NULL
a	NULL
single	NULL
regulatory	NULL
sequence	NULL
in	NULL
the	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:723-727	NULL
.	NULL

Sun	NULL
,	NULL
S.C.	NULL
,	NULL
P.A	NULL
.	NULL

Ganchi	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
D.W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-KB	NULL
transactivator	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:1346-1350	NULL
.	NULL

Grumont	NULL
,	NULL
R.J.	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1994	NULL
.	NULL

Alternative	NULL
splicing	NULL
of	NULL
RNA	NULL
transcripts	NULL
encoded	NULL
by	NULL
the	NULL
murine	NULL
p105	NULL
NF-	NULL
«	NULL
B	NULL
gene	NULL
generates	NULL
IKBy	NULL
isoforms	NULL
with	NULL
different	NULL
inhibitory	NULL
activi-ties	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:4367-4371	NULL
.	NULL

Palombella	NULL
,	NULL
V.J	NULL
.	NULL

,	NULL
O.J	NULL
.	NULL

Rando	NULL
,	NULL
A.L	NULL
.	NULL

Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
.	NULL

78:773-785	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Biswas	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
L.M	NULL
.	NULL

Carlson	NULL
,	NULL
K.D	NULL
.	NULL

Brown	NULL
,	NULL
Y.M	NULL
.	NULL

Tomita	NULL
,	NULL
A.S.	NULL
Fauci	NULL
,	NULL
and	NULL
U.K.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
expressed	NULL
exclusively	NULL
in	NULL
myelo-mono-cytic	NULL
cells	NULL
specifically	NULL
processes	NULL
the	NULL
nuclear	NULL
factor-KB	NULL
subunit	NULL
p65	NULL
in	NULL
vitro	NULL
and	NULL
may	NULL
impair	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1445-1456	NULL
.	NULL

Anderson	NULL
,	NULL
M.T	NULL
.	NULL

,	NULL
FJ	NULL
.	NULL

Staal	NULL
,	NULL
C.	NULL
Gitler	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
.	NULL

1994	NULL
.	NULL

Separation	NULL
of	NULL
oxidant-initiated	NULL
and	NULL
redox-regulated	NULL
steps	NULL
in	NULL
the	NULL
NF-KB	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:11527-11531	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IxB-a	NULL
proteolysis	NULL
by	NULL
site-spe-cific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

267:1485-1488	NULL
.	NULL

Oeth	NULL
,	NULL
PA.	NULL
,	NULL
G.C	NULL
.	NULL

Parry	NULL
,	NULL
C.	NULL
Kunsch	NULL
,	NULL
P.	NULL
Nantermet	NULL
,	NULL
C.A	NULL
.	NULL

Rosen	NULL
,	NULL
and	NULL
N.	NULL
Mackman	NULL
.	NULL

1994	NULL
.	NULL

Lipopolysaccharide	NULL
induc-	NULL
789	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72.	NULL
tion	NULL
of	NULL
tissue	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
to	NULL
a	NULL
KB-like	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3772-3781	NULL
.	NULL

Berberich	NULL
,	NULL
I.	NULL
,	NULL
G.L	NULL
.	NULL

Shu	NULL
,	NULL
and	NULL
EA	NULL
.	NULL

Clark	NULL
.	NULL

1994	NULL
.	NULL

Cross-linking	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
rapidly	NULL
activates	NULL
nuclear	NULL
factor-kB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:4357-4366	NULL
.	NULL

Lalmanach	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
T.C	NULL
.	NULL

Chiles	NULL
,	NULL
D.C.	NULL
Parker	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1993	NULL
,	NULL
T	NULL
cell-dependent	NULL
induction	NULL
of	NULL
NF-KB	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1215-1219	NULL
.	NULL

Liu	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
T.C	NULL
.	NULL

Chiles	NULL
,	NULL
RJ	NULL
.	NULL

Sen	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1991	NULL
.	NULL

Inducible	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-KB	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
stimulated	NULL
through	NULL
the	NULL
surface	NULL
Ig	NULL
receptor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146	NULL
:	NULL
1685-1691	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
ankyrin	NULL
motifs	NULL
of	NULL
inhibitory	NULL
factor	NULL
KB	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
proteins	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sc	NULL
.	NULL

USA	NULL
.	NULL

91:3584-3588	NULL
.	NULL

Dobrzanski	NULL
,	NULL
P.	NULL
,	NULL
R.P	NULL
.	NULL

Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
interactions	NULL
of	NULL
Rel-NF-	NULL
«	NULL
B	NULL
complexes	NULL
with	NULL
IKBa	NULL
determine	NULL
polls	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
NF-KB	NULL
activity	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:4608-4616	NULL
.	NULL

Liou	NULL
,	NULL
H.C.	NULL
,	NULL
W.C.	NULL
Sha	NULL
,	NULL
M.L	NULL
.	NULL

Scott	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1994	NULL
.	NULL

Sequential	NULL
induction	NULL
of	NULL
NF-KB/Rel	NULL
family	NULL
proteins	NULL
during	NULL
B-cell	NULL
terminal	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5349-5359	NULL
.	NULL

Burkly	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
L.	NULL
Ogata	NULL
,	NULL
C.	NULL
Reilly	NULL
,	NULL
L.A.	NULL
Marconi	NULL
,	NULL
D.	NULL
Olson	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
R.	NULL
Cate	NULL
,	NULL
and	NULL
D.	NULL
Lo	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
relB	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
thymic	NULL
medulla	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

373:531-536	NULL
.	NULL

